ICCN 2016 INTERNATIONAL CONFERENCE on CANCER NURSING
Program Embracing globalization through leadership and partnership in cancer care CELEBRATING
INTERNATIONAL CONFERENCE ON CANCER NURSING
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
C anCer nursing CanCer nursing ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
The Official Journal of the International Society of Nurses in Cancer Care The Official Journal of the International Society of Nurses in Cancer Care The Official Journal of the International Society of Nurses in Cancer Care Impact Impact Factor: Factor: Impact 1.931* 1.931* Factor: 1.931*
Editor-in-Chief Pamela S. Hinds, PhD, RN, FAAN Editor-in-Chief Pamela S. Hinds, PhD, RN, FAAN
Each bimonthly issue of CanCer nursing™ addresses the whole spectrum Editor-in-Chief Pamela S. Hinds,of Each bimonthly issue of CanCer nursing™ addresses the whole spectrum ofPhD, RN, FAAN problems arising in the care and support of™ cancer patients, such as: problems arisingissue in theofcare and support patients, such spectrum as: Each bimonthly CanCer nursingof cancer addresses the whole of • psychosocial aspects of cancer • prevention and early detection problems arising in caredetection and support of cancer patients, suchaspects as: of cancer • psychosocial • prevention andthe early • patient responses to all treatment • geriatric and pediatric cancer nursing • patient responses to all • geriatric andand pediatric cancer nursing psychosocial aspects of treatment cancer prevention early detection modalities • medical and surgical oncology modalities medical and • patient responses to all treatment • geriatric and surgical pediatriconcology cancer nursing • specific nursing interventions. • ambulatory care • specific nursing interventions. • ambulatory modalities medical andcare surgical oncology • nutritional support nutritional support • specific nursing interventions. • ambulatory care The•journal offerssupport unparalleled coverage of cancer care delivery practices worldwide, nutritional The journal offers unparalleled coverage of cancer care delivery practices worldwide, as well as groundbreaking research findings and their practical applications. as as groundbreaking research findings and their Thewell journal offers unparalleled coverage of cancer carepractical deliveryapplications. practices worldwide, *2013 Journal Citation Reports (Thomson Reuters, 2014) as well as groundbreaking research findings and their practical applications. *2013 Journal Citation Reports (Thomson Reuters, 2014) ® ®
One One Subscription—Multiple Subscription—Multiple Ways Ways to to Access Access One Subscription—Multiple Ways to Access CancerNursingOnline.com CancerNursingOnline.com *2013 Journal Citation Reports® (Thomson Reuters, 2014)
CancerNursingOnline.com
5-K239 5-K239
2
5-K239 NCC program ad ISNCC 4C.indd 1 5-K239 NCC program ad ISNCC 4C.indd 1
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
5-K239
4/16/15 1:07 PM 4/16/15 1:07 PM
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
TABLE OF CONTENTS Welcome from the ISNCC President
4
Welcome from the Conference Chair
5
ICCN 2016 Official Partners
6
ISNCC Leadership
9
ISNCC Full & Association Members
10
ISNCC Awards
11
General Information
12
Poster Awards & Scholarships
14
Exhibits and Posters
14
Supporter Acknowledgements
16
Program 17
www.isncc.org
Poster Listings
37
About Our Supporters
45
ISNCC Membership
51
3
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
WELCOME FROM THE ISNCC PRESIDENT Dear Colleagues in Cancer Nursing, On behalf of the Board of Directors of the International Society of Nurses in Cancer Care (ISNCC), I welcome you to the 20th International Conference on Cancer Nursing (ICCN), the premier international educational opportunity for cancer nurses. We are so glad you are here to celebrate this landmark with us! The theme for the ICCN 2016 is ‘Embracing globalization through leadership and partnership in cancer care.’ The ISNCC Conference Management Committee (CMC) worked incredibly hard to create a wonderful program that really drives home that the world is now smaller than ever, and we have unique opportunities to collaborate and build partnerships to promote excellence in cancer care. ICCN offers a unique opportunity for us to come together and exchange ideas, especially on how nurses are leading the charge in cancer care in different countries, in their own unique way. It is also an opportunity for us to support each other as we engage in leadership roles and promote evidence-based practice. I am sure that you will agree that the wealth, breadth and depth of the program is an amazing representation of all that cancer nurses are doing globally. We are also particularly pleased that we are continuing to offer joint sessions with our partners. Partnerships within nursing and with other groups with shared goals build positive synergy and we will be discussing the many ways in which they help us move forward as a Society.
4
It is also our pleasure to welcome all of you to Hong Kong. We know that the conference offers a lot of choices, but we hope you will take at least a little time to enjoy this fascinating and vibrant city. Hopefully you will go for a walk and enjoy some of the diverse history and culture, and, of course, try some of the delicious food. Most importantly, we hope you will take advantage of every opportunity to network with colleagues from around the world. Nurses from over 30 countries are at ICCN and we challenge you to engage in conversation with a colleague from a country you are not familiar with, or even with someone from a different region in your own country that you may have never met before. This is the time to take advantage of our global village and establish some new partnerships! I would also like to invite you to continue collaborating with your international colleagues by joining ISNCC as an individual member. Please visit the ISNCC registration desk during the conference and sign up for your membership. Welcome to the ICCN 2016 and wonderful Hong Kong!
Dr. Stella Aguinaga Bialous, RN, DrPH, FAAN
ISNCC President
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
WELCOME FROM THE CONFERENCE CHAIR Dear Cancer Nursing Colleagues, On behalf of the Conference Management Committee of the International Society of Nurses in Cancer Care (ISNCC), I welcome you to the International Conference on Cancer Nursing 2016 (ICCN 2016) in Hong Kong, China! This conference marks the 20th time that ISNCC has held an international conference, and we are proud and excited to share the program and this unique opportunity to meet with international cancer nurses with you! The Conference Management Committee has members from our international and regional partners and together we have planned a wonderful program that will expand your knowledge and enhance your ability to provide quality cancer care, develop innovative programs, provide cancer nursing education that is essential to healthcare’s future, and successfully conduct oncology nursing research. The theme for this year’s conference is “Embracing globalization through leadership and partnership in cancer care.” Presentations will focus on ways that oncology nurses provide leadership and partnership to make a difference in how cancer care is practiced, ensuring that patients and families receive the most up-to-date, evidenced-based care possible within our practice settings and that our educational institutions develop the foundation nurses need to provide the care patients need and deserve. Our goal is to share knowledge and experiences of leadership and partnering with others to provide quality cancer care across the globe.
www.isncc.org
I am particularly delighted to welcome you to Hong Kong, a city that never sleeps. The city is filled with fabulous tax-free shopping, exciting nightlife and thousands of eateries ranging from gourmet restaurants to fun street stalls. Attend your selected ICCN 2016 sessions and then get out and enjoy all that Hong Kong has to offer. Take a ride on a tram, a ferry or the light rail to see the amazing tourist attractions or visit a park, walk along the beach or visit an outlying island. Enjoy a guided tour or self-guided walk – whatever you choose to enjoy this fabulous city! While at ICCN 2016, I hope you will take the opportunity to network with other cancer nurses, share new experiences and information, and make and renew friendships. The meeting offers a wide variety of educational opportunities including plenary speakers, oral and rapid fire presentations, instructional sessions, and poster sessions as well as social and cultural events. I invite you to enjoy this unique opportunity to meet and collaborate with cancer nurses from all over the world. Welcome to ICCN 2016 and the wonderful, cosmopolitan city of Hong Kong!
Linda U. Krebs, PhD, RN, AOCN, FAAN Conference Management Committee, Chair
5
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
ICCN 2016 OFFICIAL PARTNERS
On behalf of the Asian Oncology Nursing Society (AONS), I welcome you to the International Conference on Cancer Nursing (ICCN) 2016 with an important theme ‘Embracing globalization through leadership and partnership in cancer care’. Cancer is a global health issue and cancer nurses play a vital role to lead and be a strong voice in the multi-disciplinary team. It is very crucial that cancer nurses worldwide participate in this conference to learn and share knowledge with one another, and discuss how to deliver the best care for our cancer patients and their family. It is a great pleasure for AONS to work hand-in-hand with ISNCC on advancing knowledge and practice in cancer care through the ICCN 2016. We are very excited to be part of this global conference. We sincerely hope you will also join the AONS international partner joint session on Wednesday 7th September 2016 from 1:50pm – 2:50pm. We will have three speakers to discuss the roles and challenges of nursing leadership in multidisciplinary cancer care. Please come and visit the AONS booth, chat with some of our board members, and learn more information about AONS, our official journal Asia-Pacific Journal of Oncology Nursing (APJON), and the 3rd AONS conference to be held in September 2017 in Beijing. We wish you a fruitful and enjoyable conference in the vibrant city of Hong Kong!
Winnie So, PhD, RN President, AONS
On behalf of the Hong Kong College of Medical Nursing and Hong Kong Oncology Nursing Group, it is a great pleasure for me to welcome you all to the 20th anniversary ICCN 2016 in Hong Kong, one of the cities most vibrant with life and energy. It is an honor for our organization to be a conference partner of ICCN 2016. Geographically and culturally speaking, Hong Kong is a key gateway to the mainland China. It serves as a bridge between the West and the East; thus a diverse blending of the western and the Chinese medical treatment. In this respect, we are very pleased to have a joint session titled ‘Enhance Quality of Oncology Care and Services Through Leadership and Collaborations’ conducted by the Chinese Nurses Association and HKCMN Oncology Nursing Group during the conference. The theme “Embracing globalization through leadership and partnership in cancer care’” for ICCN 2016, highlights the issues addressing global cancer burden and the strong leadership from multiple partners being required to address multiple barriers to mitigate these ongoing global cancer disparities. We are pleased that many of our members will participate actively in the conference to share their knowledge. This is a tremendous opportunity for our members to meet international cancer nursing leaders from around the world, network on key cancer and oncology nursing issues, and make long-lasting professional connections. It is a privilege for HKCMN and Hong Kong Oncology nurses to work hand-in-hand with ISNCC on advancing cancer care through ICCN 2016. We wish you an enjoyable and stimulating conference as well as a pleasant and memorable stay in Hong Kong!
Helena Li, RN, FHKAN President, HKCMN
6
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
The European Oncology Nursing Society (EONS) is delighted to welcome delegates to the 2016 International Conference on Cancer Nursing. The International Conference on Cancer Nursing (ICCN 2016) will be held in Hong Kong, China from September 4th through 7th, 2016. The theme for the conference is Embracing globalization through leadership and partnership in cancer care. The goal of the conference is to showcase ways in which cancer nurses provide leadership and create partnerships to promote quality cancer care around the globe. EONS as a professional organisation acts as a voice for cancer nursing across Europe and is an important partner in multi-organisational efforts to improve cancer care and patient outcomes. One of our major aims, in cooperation with our member Oncology Nursing Societies and other stakeholders, is to develop cancer nursing as a specialism in all European countries using a variety of different methods including research, education, clinical leadership, nursing strategy, advocacy, and policy development, together with improving the collaboration between countries to improve nursing roles in cancer care. We do so to meet future patient needs, improve cancer nursing as a career and profession and positively influence cancer patients’ treatment, their lives and their future. We are really excited to be part of this global conference and look forward to working together with our cancer nursing colleagues from across the world to strengthen collaboration. We very much hope that you will join the EONS session on Wednesday, 7 September, 2016 “Enhancing Recognition of the Nursing Contribution to Cancer Care: Current Challenges and Solutions in Europe” and we hope to meet and exchange experiences with you at the EONS stand. We wish you a very productive and successful conference.
PROGRAM
Dear ICCN Conference Participants, On behalf of the International Psycho-Oncology Society (IPOS), I offer welcome greetings for your conference in Hong Kong, China, 4 - 7 of September, 2016. With IPOS members from more than 60 countries, we applaud your conference theme of Embracing globalization through leadership and partnership in cancer care. Leadership and partnership are shared themes and identified strategic priorities for IPOS. As an organization in official relations with the World Health Organization (WHO) we continue to advocate towards adoption of our Standard of Care and adoption of Clinical Practice Guidelines in Cancer Care which state: •
Psychosocial cancer care should be recognized as a universal human right;
•
Quality cancer care must integrate the psychosocial domain into routine care;
•
Distress should be measured as the sixth vital sign after temperature, blood pressure, pulse, respiratory rate and pain.
As nursing professionals, you are essential, valued members of healthcare teams addressing the psychosocial aspects of cancer. We support your continued professional development and we offer you best wishes for an engaging, fruitful conference. Best regards, Luzia Travado, PhD Head of Psycho-Oncology Champalimaud Clinical Centre, Lisboa, Portugal President, International Psych-Oncology Society (IPOS)
Daniel Kelly, PhD, MSc, BSc, RN, FRCN President, EONS
www.isncc.org
7
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Welcome from CNA! The Multinational Society of Supportive Care in Cancer (MASCC) is pleased to be partnering with the International Society of Nurses in Cancer Care by presenting a plenary session in the International Conference on Cancer Nursing in Hong Kong. The focus of MASCC is that supportive care is the key to making excellent cancer care possible. Cancer nurses spend much of their time delivering excellent supportive care.
Dear Friends and Colleagues,
Many of the sessions in this meeting are highly relevant to both Societies. Supportive care spans the spectrum of cancer care from diagnosis, through treatment and then survivorship and palliative care. Supportive care embraces both the management of the side effects of cancer treatment as well as the symptoms of cancer.
The theme of this session is “Enhance quality of oncology care and services through leadership and collaborations”. It is our honor to have Professor Suzanne So-Shan Mak and Dr. Yong-Yi Chen share information with us about their amazing achievements and opinions on this topic. We look forward to this session offering you the most up-to-date scientific discoveries and practices, and a chance to share the latest experiences and advancements in the field.
Research has been important in delivering more effective means of treating some side effects such as vomiting or developing neutropenia after therapy. Other side effects such as dyspnea and fatigue are proving more challenging. The psychosocial and spiritual issues faced by cancer survivors are important to address to ensure an ongoing maximization of quality of life. The joint plenary session will explore the emerging field of the management of peripheral neuropathy after chemotherapy as well as examining the oncology nurse’s role in delivering survivorship care. We trust that you will find this session valuable and look forward to further sharing our supportive care interests in the future.
On behalf of the Chinese Nurses Association we are happy to welcome you to ICCN 2016 in beautiful Hong Kong! We take great pleasure in inviting you to attend the Plenary Session co-hosted by the Chinese Nurses Association and Hong Kong Oncology Nursing Group.
It is a great pleasure to be able to host such a fabulous session at the 20th ICCN. Hong Kong is one of the most attractive and modern cities in the world. We wish you a successful conference and a truly rewarding week in Hong Kong. Sincerely, Bo Xu Director of Oncology Nursing Committee, Chinese Nurses Association
Professor Ian Olver, AM, MD, PhD MASCC President
8
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
ISNCC LEADERSHIP Board of Directors President: Stella Bialous, USA President Elect: Patsy Yates, Australia Secretary/Treasurer: Janice Stewart, Canada Communications Portfolio: Yongyi Chen, China Conference Management Portfolio: Linda Krebs, USA Corporate and Philanthropic Development Portfolio: Annie Young, United Kingdom Knowledge Development and Dissemination Portfolio: Susan Beck, USA Member Development Portfolio: Andrew Dimech, United Kingdom Policy Portfolio: Yael Ben Gal, Israel
Awards and Nominations Committee CHAIR: GRETA CUMMINGS, CANADA Susan Beck, USA Stella Bialous, USA Andrew Dimech, United Kingdom Esther Green, Canada Catherine Johnson, Australia Tish Lancaster, Australia Winnie So, China
Conference Management Committee CHAIR: LINDA KREBS, USA Eva Gallagher, USA Violeta Lopez, Singapore Donna Milne, Australia Paranee Phongnopakoon, Thailand Winnie So, China Marise Dutra Souto, Brazil Leanne Stone, Australia Annie Young, United Kingdom AONS Representative: Yeur-hur Lai, Taiwan AONS Representative: Sui-whi Jane, Taiwan Chinese Nurses Association Representative: Zhenqi Lu, China EONS Representative: Mary Wells, United Kingdom
Hong Kong Oncology Nursing Group Representative: Suzanne Mak, China IPOS Representative: Wendy Lam, China MASCC Representative: Alex Molasiotis, China
Corporate and Philanthropic Development Committee CHAIR: ANNIE YOUNG, UNITED
Communications Committee CHAIR: YONGYI CHEN, CHINA Cynthia Abarado, USA Lili Hou, China Catherine Johnson, Australia Daniel Kelly, United Kingdom Kyung Hee Lim, Korea Ling Wai Man, China Joshua (Ngwang) Menang, Cameroon Jane Phillips, Australia Member Development Liaison: Andrew Dimech, United Kingdom
www.isncc.org
KINGDOM
Susan Cruickshank, United Kingdom Julia Downing, Uganda Catherine Johnson, Australia Elaine Lennan, United Kingdom Airong Lu, China Kevin Schreffler, USA Nwozichi Chinomso Ugochukwu, Nigeria
Finance and Audit Committee CHAIR: JANICE STEWART, CANADA Stella Bialous, USA Catherine Johnson, Australia Linda Krebs, USA Patsy Yates, Australia Annie Young, United Kingdom
Knowledge Development and Dissemination Committee CHAIR: SUSAN BECK, USA Julia Downing, Uganda Rehana Elahi, Pakistan Jeanne Marie Erickson, USA Catherine Johnson, Australia Luís Carlos Lopes Júnior, Brazil Tish Lancaster, Australia Ayda Gan Nambayan, Philippines Shiow-Ching Shun, Taiwan Allison Steinberg, USA Policy and Advocacy Liaison: Yael Ben Gal, Israel
Member Development Committee CHAIR: ANDREW DIMECH, UNITED KINGDOM
Majeda Afeef Al-Ruzzieh, Jordan Luz Esperanza Ayala de Calvo, Colombia Marlon Garzo Saria, USA Mary Glavassevich, Canada Catherine Johnson, Australia Judi Johnson, USA Tish Lancaster, Australia Massey Nematollahi, Canada Wang Qi, China Megan Rogers, Australia Erik van Muilekom, The Netherlands Communications Liaison: Yongyi Chen, China
Policy and Advocacy Committee CHAIR: YAEL BEN GAL, ISRAEL Stella Bialous, USA Georgie Cusack, USA Anne-Marie Dewar, Australia Rebecca Doherty, Switzerland Margaret Fitch, Canada Eva Gallagher, USA Catherine Glennon, USA Virginia LeBaron, USA Jane Marsh, Australia Jane Phillips, Australia Patsy Yates, Australia
9
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
ISNCC FULL MEMBERS
10
ISNCC ASSOCIATION MEMBERS
Australia
Cancer Nurses Society of Australia (CNSA)
Australia
Gold Coast University Hospital
Australia
Icon Cancer Care
Brazil
Brazilian Oncology Nursing Society (SBEO)
Australia
Canada
Canadian Association of Nurses in Oncology (CANO-ACIO)
Westmead Cancer Care Centre Westmead Hospital
Ghana
China
Oncology Nursing Committee of Chinese Nursing Associations
National Center for Radiotherapy and Nuclear Medicine, Korle-Bu Teaching Hospital
Israel
Israel Oncology Nursing Society
Denmark
Danish Cancer Nursing Society (FSK)
Japan
The Jikei University School of Nursing
France
French Oncology Nurses’ Society (AFIC)
Japan
Tokyo Medical University
Iceland
Icelandic Oncology Nursing Society
Taiwan
Chang Gung University of Science and Technology
Taiwan
Taipei Veterans General Hospital
India
The Oncology Nurses Association of India
Taiwan
Taichung Veterans General Hospital
Thailand
Mahidol University
Japan
Japanese Society of Cancer Nursing
USA
Moffitt Cancer Center
USA
UAB School of Nursing
Netherlands
The Netherlands Nursing Oncology Society (V & VN Oncology)
Zambia
Zambia Oncology Nurses Society
New Zealand
The Cancer Nurses College
Portugal
Portuguese Oncology Nursing Association (AEOP)
Singapore
Singapore Nurses Association
South Korea
Korean Oncology Nursing Society (KONS)
Taiwan
Taiwan Oncology Nursing Society
Turkey
Turkish Oncology Nursing Society
United Kingdom
UK Oncology Nursing Society (UKONS)
USA
Oncology Nursing Society (ONS)
Zimbabwe
Hospice & Palliative Care Association of Zimbabwe
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
ISNCC AWARDS Robert Tiffany Lectureship This Lectureship was created to commemorate Robert Tiffany, the founding member and President of the International Society of Nurses in Cancer Care. Robert Tiffany was the initiator of the Biennial International Conference on Cancer Nursing. The 2016 ICCN marks the 20th Conference - a significant milestone for ISNCC and a testament to his legacy. Robert Tiffany was an inspiration to nurses around the world. The intention of the named lecture is to honour those who have a similar capacity to inspire cancer nurses of today and of the future. Myrna Myrna McLaughlin-Anderson is a Senior Advisor in the Panama Ministry of Health and has almost thirty years of experience in cancer nursing. She is also a Professor of Nursing at the University of Panama, where she teaches several pre-graduate and post-graduate courses in the School of Nursing including Adult Health, Cancer Prevention and Epidemiology, Chemotherapy and Palliative care. In 2008, she the received ISNCC’s Past Presidents’ Award in recognition of the development of Asociación Hospes Pro Cuidado Paliativo, a palliative care program in Panama. From 2009-2011, Myrna was the advisor to the Vice-Minister of Health. From that position, she was an integral component of the commission that developed the National Program of Palliative Care and the National Plan for Cancer Prevention and Control. In 2013, the Mayor of the City of Panama awarded Myrna the Key of the City in recognition of her career treating cancer patients and promoting cancer nursing education.
Distinguished Merit Award The ISNCC Distinguished Merit Award is given in recognition of an outstanding member who has contributed to the international advancement of the science and art of cancer nursing. Professor Sanchia Aranda is the CEO of Cancer Council Australia. She has more than 30 years’ experience in cancer control as a clinician, researcher, educator and senior healthcare administrator. She has extensive experience in health-system administration and most recently was Director of Cancer Services and Information and Deputy CEO at the Cancer Institute New South Wales. Professor Aranda is President-Elect of the Union for
www.isncc.org
International Cancer Control (UICC) and a former President of ISNCC. As well as being a research fellow at the Peter MacCallum Cancer Centre, she holds academic appointments at the School of Health Sciences, University of Melbourne, and the Faculty of Nursing, University of Sydney. Widely published in Australian and international health literature, Professor Aranda has also conducted research reviews for the National Health and Medical Research Council, Australian Research Council, Cancer Councils, state nursing boards and private sector research funding bodies. As CEO of Australia’s top non-government cancer control organization, Professor Aranda is a strong independent voice on evidence-based cancer control. She is engaged in all fields of cancer from primary prevention through to survivorship and advanced care, and has a particular professional interest in improved ways to care for and support cancer patients.
Past Presidents’ Award The ISNCC Past Presidents’ Award is given in recognition of a cancer nurse from a low resource country who has initiated and sustained a program of cancer care in her/his country that has been in place for three or more years and has the potential for replication of adaptation beyond the country’s borders. Naomi Oyoe Ohene Oti has been working in the field of oncology for the past fourteen years. She leads oncology nursing training at the National Centre for Radiotherapy and Nuclear Medicine in Korle Bu, Ghana. She has been pivotal in oncology nursing education at her facility and in Ghana. In 2002 Naomi travelled to the Mayo Clinic in the USA where she was trained in the coordination of clinical trials. In this role, she identified and learned the critical role of the oncology nurse and its impact on delivery of quality care to cancer patients. The Mayo program inspired her to pursue formal training in oncology. Naomi used her training to institute a variety of in-house training programs that have enabled nurses to deliver quality cancer care. Naomi is now the focal person for oncology nursing training for Ghana’s Ministry of Health. In 2014 and 2015 she was among a team of specialists who developed the Postgraduate Clinical Oncology Nurse Specialist curriculum for the Ghana College of Nurses and Midwives. Naomi was also a recipient of an ISNCC conference scholarship to the 13th ICCN in Sydney, Australia. 11
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
GENERAL INFORMATION Venue Sheraton Hong Kong Hotel & Towers • 20 Nathan Road, Kowloon, Hong Kong • Phone: 852.2369.1111
1a
1 1b
1. TANG 1a. TANG II 1b. TANG I 2. SECRETARIAL 1 3. SECRETARIAL 2
2
GRAND BALLROOM
3
PREFUNCTION AREA
A
B
C
THIRD FLOOR
1a 1
3
1b
SUNG II 2
SUNG SUNG I
4 1. MING 1a. MING II 1b. MING I 2. MING TERRACE 3. CHING 4. CHING TERRACE
FOURTH FLOOR
12
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
Included In Your Registration Fee Full-conference registered attendees receive: • • • • •
Access to all Scientific and Concurrent Sessions Access to Posters and Exhibits Program Materials Admission to the Welcome Reception Food and Beverages, including: Lunch at Corporate Symposia Hors d’oeuvres and one drink ticket for the Welcome Reception Break refreshments
Exhibit-only attendees receive: •
Access to Posters and the Exhibit Hall
Registered guests receive: • •
Access to Posters and the Exhibit Hall Access to the Welcome Reception
Registration The Registration Desk is located in the Tang Foyer. Registration hours are as follows: Saturday, September 3, 2016 Sunday, September 4, 2016 Monday, September 5, 2016 Tuesday, September 6, 2016 Wednesday, September 7, 2016
5.00pm – 7.00pm 8.00am – 7.30pm 7.00am – 6.30pm 7.00am – 6.30pm 7.00am – 4.00pm
Mentor Program:
PROGRAM
Continuing Education Credit Information: ISNCC is approved by the California Board of Registered Nursing, Provider Number 16617, for a maximum of 21.85 Contact Hours. Continuing education credits are offered for the preconference workshops, plenary and concurrent abstract sessions. In order to received credit, participants must attend at least one session and fill out the online record of attendance and evaluation forms. Certificates will be emailed within 6 - 8 weeks of the conference.
Speaker Services Centre The Speaker Services Centre, located in the Group Lounge, is equipped with laptop PC computers for all faculty members to review their presentations before their sessions. To better serve you, your presentation should be uploaded at least 24 hours prior to your session. It can be previewed up to 3 hours prior to your session. The Speaker Services Centre hours are as follows: Sunday, September 4, 2016 Monday, September 5, 2016 Tuesday, September 6, 2016 Wednesday, September 7, 2016
8.00am – 7.30pm 7.00am – 6.30pm 7.00am – 6.30pm 7.00am – 3.00pm
Language The official language of the Conference is English.
Abstract Book The Mentor Program provides a detailed orientation for first time delegates attending the ICCN. Mentors will describe the meeting in general, how to interpret the conference program, how to best work out which sessions to attend, and how to benefit from the poster sessions, as well as practical matters such as meal breaks and what to expect from social functions. Mentees may be introduced to colleagues who work in similar areas of specialty and be advised of how to network with cancer nursing professionals from around the globe. A “Meet your Mentor” session is scheduled for Monday, September 5 from 7.00am – 8.00am in Ballroom A for mentors and mentees to connect.
www.isncc.org
Oral and poster abstracts will be published in the ISNCC Cancer Nursing abstract supplement alongside the November/December issue. The abstracts to be included in the Abstract Supplement will be published as they were submitted by the authors. The ICCN 2016 Conference Management Committee has not altered the submissions for inclusion. Author’s credentials have been included where submitted.
Certificates of Attendance You will receive an electronic Certificate of Attendance 4 - 6 weeks after the meeting. 13
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
POSTER AWARDS & SCHOLARSHIPS People’s Choice Poster Award The People’s Choice Poster Award is your chance to select the poster you feel is the best during each poster session. Each ICCN participant has the opportunity to take part in the selection of the daily People’s Choice Award. This award can be given to any poster presented in that day’s Poster Session regardless of category or topic. You will receive specially marked cards in your delegate badge that allow you to vote once for each Poster Session on Monday, September 5, Tuesday, September 6 and Wednesday, September 7. Votes will be tallied at the end of each day. The People’s Choice Award winners’ names will be announced and they will receive a certificate of award at the beginning of the Plenary Session the following day or at the Closing Session.
Poster Award Each day, awards will be given for the best poster, one for the category of Research and the other for all Non-Research. A team of judges fluent in both English and Mandarin along with a coordinator will evaluate the top 10 ranked posters for each grouping (research and
non-research) on each day based on scores given during the abstract review process. The poster award-winners will be announced at the Closing Session.
Conference Scholarship The ISNCC Conference Scholarships were awarded to graduate or post-graduate students from underserved population groups or those working with underserved population groups in the Asia-Pacific region to offset the costs associated with travelling to ICCN 2016. These scholarships were chosen by the ISNCC Awards and Nominations Committee. CONGRATULATIONS TO: ARIESTA MILANTI Faculty of Nursing, University of Indonesia; Jatinegara Community Health Centre, Jakarta Timur, Indonesia FAUZIA PESNANI Ziauddin Cancer Hospital, Karachi, Pakistan YUE WANG Nursing School of the Fourth Military Medical University, Xi’an, China
EXHIBITS AND POSTERS Poster Move In and Move Out Hours
Move In Time
POSTER SESSION 1
POSTER SESSION 2
POSTER SESSION 3
Sunday, September 4, 2016 3.00pm – 4.00pm
Monday, September 5, 2016 6.00pm – 6.30pm
Tuesday, September 6, 2016 6.30pm-8.30pm
Please have your poster displayed before 7.30am on Tuesday, September 6
Please have your poster displayed before 7.30am on Wednesday, September 7
Tuesday, September 6, 2016 10.30am – 10.50am 1.20pm – 1.50pm 4.20pm – 4.40pm
Wednesday, September 7, 2016 10.30am – 10.50am 1.20pm – 1.50pm
Monday, September 5, 2016 Tuesday, September 6, 2016 5.00pm – 6.00pm 5.30pm-6.30pm
Wednesday, September 7, 2016 2.00pm-3.00pm
Presentation Sunday, September 4, 2016 Hours 5.50pm – 7.40pm Monday, September 5, 2016 10.30am – 10.50am 1.20pm – 1.50pm 4.20pm – 4.40pm Move Out Time
14
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
The Exhibit Hall and Posters are located in Tang and the Tang Foyer. Posters are a wonderful educational opportunity at this conference. The Conference Management Committee received a wealth of abstracts on research, education, management and clinical practice. For your convenience the posters will be profiled each day, where delegates can “Meet the Authors”. During these sessions, authors will be present to discuss their work with you. Posters will be individually numbered and grouped by themes within the poster hall.
03
04
05
PROGRAM
Exhibit Hours Exhibits are located in Tang. Sunday, September 4, 2016 Monday, September 5, 2016 Tuesday, September 6, 2016 Wednesday, September 7, 2016
06
07
5.50pm – 7.40pm 10.20am – 4.50pm 10.20am – 4.50pm 10.20am – 2.00pm
08
02
01 09
Exhibit Booths
10
11
12
Exhibit Table Tops
BARD
08
Asian Oncology Nursing Society (AONS)
10
Dale Medical Products, Inc.
05
European Oncology Nursing Society (EONS)
01
ICU Medical
09
International Psycho-Oncology Society (IPOS)
12
NCI Center for Global Health
02
Oncology Nursing Society (ONS)
11
End-of-Life Nursing Education Consortium 07 (ELNEC) Pfizer Oncology
06
Roche
03
Teva Pharmaceuticals LTD.
04
www.isncc.org
15
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
SUPPORTER ACKNOWLEDGEMENTS The International Society of Nurses in Cancer Care (ISNCC) wishes to acknowledge the support of all of the companies and organizations who contributed generously to the 2016 International Conference on Cancer Nursing (ICCN).
Gold Level Supporter
Bronze Level Supporter
Symposia and Tutorials
NCI Center for Global Health Preconference Workshops
Conference Scholarship Supporters ISNCC would also like to thank its individual donors for support of the conference scholarships: • Susan Beck • Stella Bialous • Rebecca Chenery
• Linda Krebs • Myungsung Li • Airong Lu
• Albert Luppens • Pam Malloy • Megan Nutt
• Winnie So • Bo Xu
We would also like to thank the following organizations for their generous support: • Asian Oncology Nursing Society 16
• Cancer Nurses Society of Australia • Oncology Nursing Society September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
PROGRAM Friday 2 September 2016 7.00pm – 9.00pm
ISNCC EXECUTIVE COMMITTEE MEETING*
Saturday 3 September 2016 9.00am – 5.00pm
ISNCC BOARD OF DIRECTORS MEETING – DAY 1*
Ching
5.00pm – 7.00pm
Conference Registration Open
Tang Foyer
7.00pm – 9.00pm
ISNCC BOARD OF DIRECTORS DINNER WITH CONFERENCE MANAGEMENT COMMITTEE*
Offsite
Preconference and Welcome: Sunday 4 September 2016 Ballroom Foyer
Fruit and pastries provided.
8.00am – 7.30pm
Conference Registration Open
8.00am – 7.30pm
Speaker Services Open
9.00am – 5.00pm
ISNCC BOARD OF DIRECTORS MEETING – DAY 2*
9.00am – 4.00pm
PRECONFERENCE WORKSHOP 1 – END-OF-LIFE NURSING EDUCATION CONSORTIUM*** Hosted by End-of-Life Nursing Education Consortium (ELNEC)
Tang Foyer Group Lounge Ching Sung
SPEAKERS: PAM MALLOY, USA, JUDITH PAICE, USA AND CHERYL ANN THAXTON, USA
The End-of-Life Nursing Education Consortium (ELNEC) project is a national education initiative to improve palliative care through education. During the 16 years of this project, over 20,700 nurses and other healthcare professionals, representing all 50 states, plus 88 international countries have received ELNEC training. During this 1-day course, you will receive education on palliative care related to pain and symptom management, communication, loss/grief/bereavement, and final hours of life. You will also receive a flash drive housing the entire 2016 ELNEC-Core curriculum so you can take this education back to your institution and educate others. For more information about ELNEC, go to www. aacn.nche.edu/ELNEC 9.00am – 12.00pm
PRECONFERENCE WORKSHOP 2 – GLOBAL ISSUES OF SURVIVORSHIP*** Hosted by ISNCC, CANO-ACIO and ONS
Ming
SPEAKERS: SUSAN M. SCHNEIDER, USA, TRACY TRUANT, CANADA, MARY WELLS, UNITED KINGDOM, TOMOKO IZAWA, JAPAN, RAY CHAN, AUSTRALIA AND DEBORAH WALKER, USA
Global Perspectives on Cancer Survivorship, hosted by the Oncology Nursing Society (ONS), the Canadian Association of Nurses in Oncology (CANO-ACIO) and the International Society of Nurses in Cancer Care (ISNCC), will address major topics associated with nursing management of cancer survivorship including: 1) the history, influences and primary definitions of cancer survivorship; 2) development, use and controversies of cancer survivorship care plans; and 3) managing cancer survivorship across the globe.
www.isncc.org
* By invitation only ***Pre-registration required
17
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Preconference and Welcome: Sunday 4 September 2016 10.00am – 12.00pm PRECONFERENCE WORKSHOP 3 – TRADITIONAL CHINESE MEDICINE (MANDARIN)
Ballroom A
CHAIRS: KIM-HUNG LEE, CHINA AND MANDY SAU-MAN, CHINA
The Nine Body Constitutions in Chinese Medicine and Acupressure for Symptom Management for Patients with Cancer SPEAKER: WAI-LING LIN, CHINA
1.00pm – 4.00pm
PRECONFERENCE WORKSHOP 4 – PUBLISHING WORKSHOP*** Hosted by the European Journal of Oncology Nursing
Ming
SPEAKER: ALEX MOLASIOTIS, CHINA
This session will focus on taking participants through the publication process, from identifying the reasons for writing to having an article published, and highlight some major mistakes people often make, particularly those less experienced researchers, in their attempt to disseminate their piece of work. Some ‘tips’ for preparing papers for submission for publication, based on editorial experiences of many years, will also be shared in order to help participants increase their publication success. 12.00pm – 4.00pm
EXHIBIT AND POSTER SESSION 1 MOVE IN Exhibitors Move In: 12.00pm – 4.00pm Poster Session 1 Move In: 3.00pm – 4.00pm
2:00pm – 4:00pm
PRECONFERENCE WORKSHOP 5 - TRADITIONAL CHINESE MEDICINE (ENGLISH)
Tang & Tang Foyer
Ballroom A
CHAIRS: KIM-HUNG LEE, CHINA AND MANDY SAU-MAN, CHINA
The Nine Body Constitutions in Chinese Medicine and Acupressure for Symptom Management for Patients with Cancer SPEAKER: WAI-LING LIN, CHINA
5.50pm – 7.40pm
EXHIBITS AND POSTER SESSION 1 OPEN
Tang & Tang Foyer
6.00pm – 7.30pm
WELCOME RECEPTION WITH EXHIBITS AND POSTER SESSION 1 Come join us for a drink and hors d’oeuvres to celebrate the opening of the 20 th ICCN!
Tang & Tang Foyer
6.30pm Welcome Remarks SPEAKERS: STELLA BIALOUS, USA AND LINDA KREBS, USA
Conference Day 1: Monday 5 September 2016 Ballroom Foyer
Fruit and pastries provided.
18
7.00am – 6.30pm
Conference Registration Open
7.00am – 6.30pm
Speaker Services Open
7.00am – 8.00am
ISNCC POLICY AND ADVOCACY COMMITTEE MEETING
* By invitation only ***Pre-registration required
Tang Foyer Group Lounge
Business Centre
ISNCC KNOWLEDGE DEVELOPMENT AND DISSEMINATION COMMITTEE MEETING
Ching
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Conference Day 1: Monday 5 September 2016 7.00am – 8.00am 8.00am – 9.00am
MEET YOUR MENTOR OFFICIAL OPENING AND KEYNOTE 8.00am – 8.05am 8.05am – 8.15am 8.15am – 8.25 am
8.25am – 9.00am
Ballroom A Ballroom BC
GREETINGS BY ISNCC CMC CHAIR LINDA KREBS, USA
WELCOME ADDRESS BY ISNCC PRESIDENT STELLA BIALOUS, USA
OPENING CELEBRATIONS BY LION DANCERS
ROBERT TIFFANY LECTURESHIP AND KEYNOTE ADDRESS
Ballroom BC
CHAIR: STELLA BIALOUS, USA
Supported by Royal Marsden Trust Building Capacity for Cancer Care, While Facing Global Challenges and Transferring Knowledge SPEAKER: MYRNA MCLAUGHLIN DE ANDERSON, PANAMA
9.10am – 10.30am Concurrent Sessions
CONCURRENT SESSION A1: CULTURAL DIVERSITY CHAIR: CARLA REMONDINI, USA
9.10am – 9.25am
9.25am – 9.40am
9.10am – 10.30am Concurrent Sessions
www.isncc.org
Ballroom BC
OE-1. Demographic Predictors of Breast Cancer Screening Behaviors Among Immigrant Women in Australia CANNAS KWOK, AUSTRALIA
OE-2. The Impact of Chemotherapy on Patients >65 Years CAROLE FARRELL, UNITED KINGDOM
9.40am – 9.55am
OE-3. Validation of Breast Cancer Screening Beliefs Questionnaire in Five Versions
9.55am – 10.10am
OE-4. If it Works Here, We Can Make it Work There! Flexibility is Key to Diverse Education
10.10am – 10.25am
OE-5. Closing the Gap: Implementation of a National Cancer Nurse Coordination Program
CANNAS KWOK, AUSTRALIA
ANET JULIUS, CANADA
NATALIE JAMES, NEW ZEALAND
CONCURRENT SESSION A2: CARE DELIVERY – 1 CHAIR: ELAINE LENNAN, UNITED KINGDOM
Ballroom A
9.10am – 9.25am
OE-6. A Nurse-Led, Immunotherapy Telephone Assessment Service to Improve Waiting Times
9.25am – 9.40am
OE-7. Examining the Role of the Advanced Nurse Practitioner within an Oncology Clinical Trials Service
9.40am – 9.55am
OE-8. Impact Evaluation of Integrated Holistic Care Model for Cancer Patients Receiving Chemotherapy
JOANNE UPTON, UNITED KINGDOM
MICHELLE DAVIES, UNITED KINGDOM
PENSUPA SRIJARAT, THAILAND
19
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Conference Day 1: Monday 5 September 2016 9.10am – 10.30am Concurrent Sessions
9.10am – 10.30am Concurrent Sessions
9.55am – 10.10am
OE-9. Nurse Led Clinic for Head and Neck Cancer Patients on Chemotherapy Treatment – A New Service
10.10am – 10.25am
OE-10. An Emerging Service Model: In Patient Clinical Care Manager (IPCCM) for Cancer Patient
Concurrent Sessions
KAM SHING HO, CHINA
CONCURRENT SESSION A3: HEALTH PROMOTION
Sung
CHAIR: VIOLETA LOPEZ, SINGAPORE
9.10am – 9.25am
OE-11. The Eastern Europe Nurses’ Centre of Excellence for Tobacco Control: A Multinational Project
9.25am – 9.40am
OE-12. Nurses Handling Cytotoxic Drugs is Critical: Outcomes of a 20-Year Follow Up Study
9.40am – 9.55am
9.10am – 10.30am
DEBRA FARRELL, AUSTRALIA
STELLA BIALOUS, USA
ANNA TOMPA, HUNGARY
OE-13. Educating the Leukemia Population KAMINIBEN PATEL, CANADA, CHRISTINE BENT, CANADA AND SANDRA BOLYKI, CANADA
9.55am – 10.10am
OE-14. Successful Measures in Prevention of Oncology In-Patient Suicide in QMH of HK
10.10am – 10.25am
OE-15. Development of Training Curriculum in Sexual Health for the Postoperative Breast Cancer Patients
KITHELIA LAI, CHINA
PEI-PEI WU, CHINA
INSTRUCTIONAL SESSION A4: GLOBAL PARTNERSHIPS ENHANCE PALLIATIVE CARE AND ONCOLOGY EDUCATION FOR NURSES
Ching
CHAIR: DEBORAH WALKER, USA
SPEAKERS: DEBORAH WALKER, USA, MARIE BAKITAS, USA AND REBECCA SIPPLES, USA
Learning Objectives: 1. Describe the methods that have enhanced palliative care and oncology curricula for nurses in Malawi, Turkey and Alabama, USA. 2. Describe resulting sustainable global partnerships in research, education and practice. 10.20am – 4.50pm
EXHIBITS AND POSTER SESSION 1 OPEN
10.30am – 10.50am Coffee/Tea Break with Exhibits and Poster Session 1 10.50am – 12.10pm CONCURRENT SESSION B1: PALLIATIVE & END OF LIFE CARE – 1 Concurrent Sessions
Tang & Tang Foyer Ballroom BC
CHAIR: JANE PHILLIPS, AUSTRALIA
10.50am – 11.05am
20
Tang & Tang Foyer
OE-16. The Burden of Decision Making Regarding the Place of End-ofLife Cancer Care on Bereaved Families SENA YAMAMOTO, JAPAN
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Conference Day 1: Monday 5 September 2016 10.50am – 12.10pm 11.05am – 11.20am Concurrent Sessions
11.20am – 11.35am
11.35am – 11.50am
11.50am – 12.05am
OE-17. Perspectives on Providing Spiritual Care MARGARET FITCH, CANADA
OE-18. Transitions in Palliative Treatment: A Patient and Family Experience JOHANNA MAREE, SOUTH AFRICA
OE-19. Spiritual Needs of Patients with Advanced Cancer in China CHANG TIAN, CHINA
OE-20. Meeting the Palliative Care Needs of Patients: Barriers for Nurses in Nigeria ADENIKE ONIBOKUN, NIGERIA
CONCURRENT SESSION B2: QUALITY & SAFETY 10.50am – 12.10pm CHAIR: LETITIA LANCASTER, AUSTRALIA Concurrent Sessions
10.50am – 11.05am
OE-21. Full Nursing Management of Breast Cancer after PICC Catheter Evaluation
11.05am – 11.20am
OE-22. Feasibility of Using Small Innovative Team Approach to Engage Oncology Nurses and Improve Quality
11.20am – 11.35am
OE-23. Cause Analysis and Nursing Countermeasures for Late Complications in Oncologic Patients with TIVAPS
11.35am – 11.50am
OE-24. Chinese Nurses’ Experience Regarding Disclosure of Medication Error to Patients and Family Members
11.50am – 12.05am
OE-25. Proactive Intentional Round to Reduce Falls – A New Fall Prevention Initiative in the Oncology Wards
RONG YAN, CHINA
KITHELIA LAI, CHINA
XINYAN YU, CHINA
FENGQI DONG, CHINA
SAU YEE CHAN, CHINA
CONCURRENT SESSION B3: SURVIVORSHIP -1 10.50am – 12.10pm CHAIR: DONNA MILNE, AUSTRALIA Concurrent Sessions
10.50am – 11.05am
11.05am – 11.20am
11.20am – 11.35am
www.isncc.org
Ballroom A
Sung
OE-26. Effectiveness of Adventure-Based Training in Reducing Fatigue among Childhood Cancer Survivors KA YAN HO, CHINA
OE-27. Yoga & Head and Neck Cancer SHEILA RIDNER, USA
OE-28. Implementing a New Programme of Follow Up after Treatment for Colorectal Cancer in the UK JANE WINTER, UNITED KINGDOM
21
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Conference Day 1: Monday 5 September 2016 10.50am – 12.10pm Concurrent Sessions
11.35am – 11.50am
OE-29. Evaluating Sexual Nursing Intervention for Cervical Cancer Survivors in Indonesia
11.50am – 12.05am
OE-30. Psychometric Performance of a Chinese Version of the FSFI in Cervical Cancer Patients
ARIESTA MILANTI, INDONESIA
HUAYUN LIU, CHINA
CONCURRENT SESSION B4: RAPID FIRE – ENGLISH 10.50am - 11.50am CHAIR: LINDA KREBS, USA Concurrent Sessions
10.50am – 11.00am
RF-E-1. A Written Handing-Over-Tool for Nurses: Educational Development
11.00am – 11.10am
RF-E-2. Quality of Life of Breast Cancer Young Women in the Republic of Panama
11.10am – 11.20am
RF-E-4. Nurse’s Role in Declotting Thrombotic Occlusion via Implanted Port in Ramathibodi Hospital
11.20am – 11.30am
12.20pm – 1.20pm
Ching
SANGEETHA SAMUEL, INDIA
MYRNA MCLAUGHLIN DE ANDERSON, PANAMA
SUWANNEE SIRILERTTRAKUL, THAILAND
RF-E-6. Delays in Elective Chemotherapy Administration CELIA DIEZ DE LOS RIOS DE LA SERNA, UNITED KINGDOM
11.30am – 11.40am
RF-E-7. Analysis of the Present Situation and Influence Factors on Smoking Control of Lung Cancer Patients
11.40am – 11.50am
RF-E-9. Implementation of Focused Educational Program to Enhance CBAD-Related Occlusion Care
MIAO LIU, CHINA
WOAN TYNG LOOI, SINGAPORE
CORPORATE LUNCH TUTORIAL SESSION Supported by NCI Center for Global Health
Ballroom BC
Update on Oncology Nursing Education and Leadership Efforts in LMICs Session
PRESENTERS: ANNETTE GALASSI, RN, MA, OCN, NURSE CONSULTANT (CONTRACTOR), NCI CENTER FOR GLOBAL HEALTH; STELLA BIALOUS, RN, PHD
Learning Objectives: • to describe results of a study of U.S. NCI Comprehensive Cancer Center about global activities in cancer nursing education and training • to identify ways in which information about global activities in cancer nursing education and training can be obtained from countries outside the U.S. • to identify potential mechanisms for sharing this information • to discuss progress to date on the oncology nursing leadership and education in low and middle-income countries project • to discuss next steps 1.20pm – 1.50pm
22
Coffee/Tea Break with Exhibits and Poster Session 1
Tang & Tang Foyer
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Conference Day 1: Monday 5 September 2016 1.50pm – 2.50pm
PLENARY SESSION I: ENHANCE QUALITY OF ONCOLOGY CARE AND SERVICES THROUGH LEADERSHIP AND COLLABORATIONS Chinese Nurses Association and Hong Kong Oncology Nursing Group Regional Partners Joint Session
Ballroom BC
CHAIR: CARENX WAI-YEE LEUNG, CHINA
How Quality of Oncology Care and Services can be Improved Through Leadership and Collaborations: Cross-Clusters CQI Program in Hong Kong SPEAKER: SUZANNE SO-SHAN MAK, CHINA
Developing an Evaluation Index System to Assess Patients’ Satisfaction with Oncology Care and Services SPEAKER: YONGYI CHEN, CHINA
Learning Objectives: 1. Identify process, trends, opportunities, and challenges posed by quality improvement initiatives. 2. Discuss the strategies through leadership and collaboration that oncology nurses can employ to get success in quality improvement of oncology care. 3. Describe tactics that help quality improvement processes to healthcare. 3.00pm – 4.20pm
Concurrent Sessions
CONCURRENT SESSION C1: SYMPTOM MANAGEMENT -1 CHAIR: TRACY TRUANT, CANADA
3.00pm – 3.15pm
OE-31. Effect of Vaginal Mould for Preventing Vaginal Stenosis in Young Patients with Cervical Cancer
3.15pm – 3.30pm
OE-32. Hermeneutic Phenomenological Reflections on Living with Treatment-Induced Cutaneous Toxicities
3.30pm – 3.45pm
OE-33. Holistic Needs Assessment in Brain Cancer: Challenges and Opportunities
3.45pm – 4.00pm
4.00pm – 4.15pm
3.00pm – 4.20pm
Concurrent Sessions
www.isncc.org
Ballroom BC
ZHEN PAN, CHINA
ANDREAS CHARALAMBOUS, CYPRUS
JANYNE AFSETH, UNITED KINGDOM
OE-34. Cytokine Changes Over Time and Symptom Development BENJAMIN SCHULTZE, USA
OE-35. Teas Ameliorate Chemotherapy-Induced Bone Marrow Suppression in Lung Cancer Patients LILI HOU, CHINA
CONCURRENT SESSION C2: HEALTH POLICY CHAIR: JUDITH JOHNSON, USA
Ballroom A
3.00pm – 3.15pm
OE-36. Research Priorities for Oncology Nursing: A Delphi Study Providing the UL Perspective
3.15pm – 3.30pm
OE-37. Dar Al Hanan; an Award Winning Effort to Reach out to the Young Patients and Help in Compliance
3.30pm – 3.45pm
OE-38. Integrating Oncology Content in Nursing Curricula in Malawi: A Fulbright Senior Specialist Experience
EMMA REAM, UNITED KINGDOM
FAIQA AL SINAWI, OMAN
DEBORAH WALKER, USA
23
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Conference Day 1: Monday 5 September 2016 3.00pm – 4.20pm
Concurrent Sessions
3.00pm – 4.20pm
Concurrent Sessions
3.45pm – 4.00pm
OE-39. Breast Cancer Early Detection and Care Strategies for Policy Makers in Nigeria
4.00pm – 4.15pm
OE-40. An Introduction of Establishing Benevolence Supermarket in Cancer Center
Concurrent Sessions
QU WEN, CHINA
CONCURRENT SESSION C3: GLOBAL CARE
Sung
CHAIR: YAEL BEN GAL, ISRAEL
3.00pm – 3.15pm
OE-41. The Discursive Construction of Ovarian Cancer in Women’s Magazines: Implications for Cancer Nursing
3.15pm – 3.30pm
OE-42. Turkish Adaptation of Cancer Behavior Inventory – Brief Version: A Validity and Reliability Study
3.30pm – 3.45pm
3.00pm – 4.20pm
AGATHA OGUNKORODE, CANADA
MERIDITH BURLES, CANADA
EMINE LYIGUN, TURKEY
OE-43. Mapping the Evidence for Cancer Rehabilitation JOANNE FISHER, UNITED KINGDOM
3.45pm – 4.00pm
OE-44. Innovative Delivery Model Supporting Visitor Experience within Cancer Centre in Western Australia
4.00pm – 4.15pm
OE-45. Survey on the Knowledge of Osteoporosis in Breast Cancer Patients Undergoing Aromatase Inhibitors
LESLEY MILLAR, AUSTRALIA
ZIFANG JIANG, CHINA
INSTRUCTIONAL SESSION C4: TRANSFORMING CANCER SURVIVORSHIP CARE – AN AUSTRALIAN EXPERIENCE
Ching
CHAIR: RAYMOND CHAN, AUSTRALIA
SPEAKERS: NICOLE KINNANE, AUSTRALIA, AND AMANDA PIPER, AUSTRALIA
Learning Objectives: 1. Understand the Australian experience of implementing innovative survivorship programs and how this transfers to a global workforce 2. Understand how to apply tools and resources to deliver survivorship care 4.20pm – 4.40pm
Coffee/Tea Break with Exhibits and Poster Session 1
4.40pm – 6.00pm
INSTRUCTIONAL SESSION D1 – CHEMOTHERAPY EXTRAVASATION: EVIDENCE BASED PRACTICE FOR PREVENTION AND MANAGEMENT
Concurrent Sessions
Tang & Tang Foyer Ballroom BC
CHAIR: TBD
SPEAKER: SHEJILA CHILLAKUNNEL HUSSAIN RAWTHER, INDIA
Learning Objectives: 1. At the end of the first session the participants will get an overview of extravasation including incidence, risk factors, signs and symptoms, knowledge gaps and controversies regarding vesicant extravasation management 2. After completion of the second session participants will be able to discuss the treatment approaches and methods to prevent complications based on current evidence guidelines
24
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Conference Day 1: Monday 5 September 2016 4.40pm – 6.00pm
Concurrent Sessions
INSTRUCTIONAL SESSION D2 – TEACHING ONCOLOGY NURSING THROUGH DISTANCE LEARNING: THE PHILIPPINE EXPERIENCE
Ballroom A
CHAIR: STELLA BIALOUS, USA
SPEAKERS: RITA RAMOS, PHILIPPINES, MARLON SARIA, USA AND LOYDA AMOR CAJUCOM, PHILIPPINES
Learning Objectives: 1. The participant will be able to describe the development of an Oncology Nursing course for graduate students provided through distance learning 2. The participant will be able to discuss the challenges of providing an Oncology Nursing course through distance learning and the various teaching-learning techniques utilized that have been perceived by students as effective in achieving the basic knowledge and skills in oncology nursing. 5.00pm – 6.00pm 6.00pm – 6.30pm
POSTER SESSION 1 MOVE OUT
Tang & Tang Foyer
POSTER SESSION 2 MOVE IN
Tang & Tang Foyer
Please have your poster displayed before 7.30am on Tuesday, 6 September.
Conference Day 2: Tuesday 6 September 2016 Pastries and fruit provided.
Ballroom Foyer
7.00am – 6.30pm
Conference Registration Open
7.00am – 6.30pm
Speaker Services Open
7.00am – 8.00am
ISNCC Communications Committee Meeting
8.00am – 9.00am
Tang Foyer Group Lounge
Business Centre
ISNCC Member Development Committee Meeting
PLENARY SESSION II International Psycho-Oncology Society (IPOS) International Partner Joint Session
Ching Ballroom BC
CHAIR: SUSAN BECK, USA
Is it the Most Frequent Unmet Supportive Care Needs that Predict Caregivers’ Anxiety and Depression? Results from Australia’s Partners and Caregivers Longitudinal Well-being Study. SPEAKER: SYLVIE LAMBERT, CANADA
Unmet Supportive Care Needs in Women with Breast Cancer Across Asia SPEAKER: RICHARD FIELDING, CHINA
Learning Objectives: 1. Recognise the similarities and differences in unmet supportive care needs in women with breast cancer from different Asian countries. 2. Identify commonalities in unmet supportive care needs across national and cultural groups of women with breast cancer from different Asian countries. 3. Infer intervention strategies to target unmet supportive care needs in women with breast cancer from different Asian countries.
www.isncc.org
25
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Conference Day 2: Tuesday 6 September 2016 9.10am – 10.30am Concurrent Sessions
CONCURRENT SESSION E1: PALLIATIVE & END OF LIFE CARE -2 CHAIR: MARGARET FITCH, CANADA
9.10am – 9.25am
Ballroom BC
OE-46. Chinese Oncology Nurses’ Knowledge and Perceived Competence in End-of-Life Care for Cancer Patients RUISHUANG ZHENG, CHINA
9.25am – 9.40am
OE-47. An Investigation of Recognition on End-of-Life Care among Oncology Nurses in Mainland China BO XU, CHINA
9.40am – 9.55am
OE-48. Audit of the Palliative Care Practitioners’ Adherence to WHO Pain Management Guidelines in Zambia PATIENCE MBOZI, ZAMBIA
9.55am – 10.10am
OE-49. A Thematic Analysis of Nursing Students’ End-of-Life Knowledge SUSANNA EDWARDS, CANADA
10.10am – 10.25am
OE-50. Medicinal Cannabis for Cancer-Related Anorexia and Cachexia: An Anonymous Patient Survey JANE PHILLIPS, AUSTRALIA
9.10am – 10.30am Concurrent Sessions
CONCURRENT SESSION E2: WORKFORCE CHAIR: EVA GALLAGHER, USA
9.10am – 9.25am
Ballroom A
OE-51. Building Capacity through Experiential Learning EMMA COHEN, AUSTRALIA
9.25am – 9.40am
OE-52. A National Cancer Nursing Workforce Development Project: Assessing Reach and Impact 10 Years On KYLIE ASH, AUSTRALIA
9.40am – 9.55am
OE-53. Improving Staff Compliance with Chemotherapy Administration: A Tawam Experience SUZANNE OAKLEY, UNITED ARAB EMIRATES
9.55am – 10.10am
OE-54. Nurses’ Physical Activity Engagement: Motivators, Barriers and Work Environment Interventions DAN LOUIE RENZ TATING, PHILIPPINES
10.10am – 10.25am
OE-55. Engaging Clinical Oncology Nursing Team with a Staff Wellness Program using Small Team Approach KA HUNG KONG, USA
9.10am – 10.30am Concurrent Sessions
MANDARIN CONCURRENT SESSION E3: QUALITY & CARE CHAIR: WENDY LAM, CHINA
9.10am – 9.25am
Sung
OM-1. Cultural Barriers to Family Caregiving LICHYUN YEH, TAIWAN
9.25am – 9.40am
OM-2. Three Kinds of External Use in the Prevention Effect of Radiation Dermatitis LUO XIA, CHINA
26
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Conference Day 2: Tuesday 6 September 2016 9.10am – 10.30am
9.40am – 9.55am
OM-3. Applying Winter Camp as Strategy of Nursing Recruitment SHIHPING PAN, TAIWAN
Concurrent Sessions
9.55am – 10.10am
OM-4. Effects of Ionizing Irradiation on Physical Properties of a Peripherally Inserted Central Catheter TING ZHANG, CHINA
10.10am – 10.25am
OM-5. Medication Status of Cancer Patients with Oral Chemotherapy in Home RONG ZHOU, CHINA
9.10am – 10.30am Concurrent Sessions
INSTRUCTIONAL SESSION E4: PATIENT AND PUBLIC INVOLVEMENT IN CANCER: PUTTING THE RHETORIC INTO ACTION
Ching
CHAIR: MEGAN ROGERS, AUSTRALIA
SPEAKERS: JANYNE AFSETH, UNITED KINGDOM, SUSANNE CRUICKSHANK, UNITED KINGDOM AND VIVIENNE WILSON, UNITED KINGDOM
Learning Objectives: 1. Participants will be able to assess the appropriateness of different methods and strategies for PPI in their work to enhance involvement in healthcare research and service development 2. Participants will be able to critically participate in debates about the assessment of impact of PPI and to evaluate its effectiveness. 10.20am – 4.50pm
EXHIBITS AND POSTER SESSION 2 OPEN
10.30am – 10.50am Coffee/Tea Break with Exhibits and Poster Session 2 10.50am – 12.10pm
Concurrent Sessions
CONCURRENT SESSION F1: SYMPTOM MANAGEMENT -2 CHAIR: PATSY YATES, AUSTRALIA
10.50am – 11.05am
Tang & Tang Foyer Tang & Tang Foyer Ballroom BC
OE-56. A Combined Content and Thematic Analysis of Advanced Lung Cancer Patients’ Exercise Experience PI-HUA CHANG, TAIWAN
11.05am – 11.20am
OE-57. A Study of Platinum-Based Chemotherapy-Induced Nausea and Vomiting, and Psychological Status QIANQIAN MOU, CHINA
11.20am – 11.35am
OE-59. Acute Oncology Chemotherapy and Radiotherapy Triage Clinic JEANETTE RUSSELL, UNITED KINGDOM
11.35am – 11.50am
OE-60. Systematic Review of Non-Pharmacological Methods to Minimize Salivary Gland Damage Following RAI ANDREAS CHARALAMBOUS, CYPRUS
CONCURRENT SESSION F2: CARE DELIVERY -2 10.50am – 12.10pm CHAIR: ANNIE YOUNG, UNITED KINGDOM
Ballroom A
Concurrent Sessions
10.50am – 11.05am
OE-61. The Effectiveness of Spiritual Care on Reducing Depression Symptoms in Patients with Cancer DI WEI, CHINA
www.isncc.org
27
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Conference Day 2: Tuesday 6 September 2016 10.50am – 12.10pm
11.05am – 11.20am
Concurrent Sessions
OE-62. Implementing an Electronic Oncology Assessment Tool: Improving Communication and Patient Outcomes SUZANNE OAKLEY, UNITED ARAB EMIRATES
11.20am – 11.35am
OE-63. Impact of Switching from IV to SC Trastuzumab (TX) in the Management of HER2 Positive Breast HELEN ROE, UNITED KINGDOM
11.35am – 11.50am
OE-64. Medication Adherence of Oral Chemotherapy in Chinese Colorectal Cancer Patients SIYU YANG, CHINA
11.50am – 12.05am
OE-65. The Research of Applying WeChat to Transitional Care for the Postoperative Breast Cancer Patients DI WEI, CHINA
MANDARIN CONCURRENT SESSION F3: SYMPTOMS & CARE 10.50am – 12.10pm CHAIR: AIRONG LU, CHINA Concurrent Sessions
10.50am – 11.05am
Sung
OM-6. The Application of No Vomiting Standardized Ward Nursing Work Mode in Medical Oncology Department YANG WANG, CHINA
11.05am – 11.20am
OM-7. Observation on New Soft Silicone Dressing to Prevent Radioactive Skin Lesion in Breast Cancer GUI WU, CHINA
11.20am – 11.35am
OM-8. The Humidification Effect of Portable Spray Bottle on OutHospital Patients after Total Laryngectomy QINGFENG WEI, CHINA
11.35am – 11.50am
OM-9. The Impact of Multidisciplinary Continuous Nursing on Mental State of Patients with Breast Cancer XINCHUN ZHANG, CHINA
11.50am – 12.05am
OM-10. Death Attitudes in Family Caregivers of Cancer Patients: A Questionnaire Survey TING ZHANG, CHINA
CONCURRENT SESSION F4: RAPID FIRE – ENGLISH 10.50am - 11.50am CHAIR: DAVID LARKIN, AUSTRALIA Concurrent Sessions
10.50am – 11.00am
Ching
RF-E-13. Effects of Nurse-Led Fast Track Programme in Laparoscopic Colorectal Surgery QIAN WU, CHINA
11.00am – 11.10am
RF-E-15. Application of Health Belief Model Education in the Rehabilitation of Breast Cancer Patients MENGQING SUN, CHINA
11.10am – 11.20am
RF-E-16. Impact Evaluation of Integrated Holistic Care Model for Cancer Patients Receiving Chemotherapy KATEKANOK KAMONMARTTAYAKUL, THAILAND
28
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Conference Day 2: Tuesday 6 September 2016 10.50am - 11.50am
11.20am – 11.30am
Concurrent Sessions
RF-E-18. Liver Cancer Patients Eat Well and Experience Little Nausea after Discharge when Treated with ERP AANNA – MARIA HILTUNEN, FINLAND
11.30am – 11.40am
RF-E-19. The Impact of Depression on Healthcare Utilization in Home Care Recipients with or without Cancer JINJIAO WANG, USA
11.40am – 11.50am
RF-E-20. Effect of Education on Recognition of Breast Prosthesis in Breast Cancer Patients with Mastectomy HONG XIA GAO, CHINA
12.10pm – 1.20pm
Lunch in Exhibit Hall
Tang & Tang Foyer
1.20pm – 1.50pm
Coffee/Tea Break with Exhibits and Poster Session 2
Tang & Tang Foyer
1.50pm – 2.50pm
PLENARY SESSION III Multinational Association of Supportive Care in Cancer (MASCC) International Partner Joint Session
Ballroom BC
CHAIR: ANNIE YOUNG, UNITED KINGDOM
Peripheral Neuropathies After Chemotherapy: A Challenging and Under-researched Symptom SPEAKER: ALEX MOLASIOTIS, CHINA
Perceptions of the Role of Oncology Nurse in Delivering Survivorship Care SPEAKER: VIOLETA LOPEZ, SINGAPORE
3.00pm – 4.20pm
Concurrent Sessions
CONCURRENT SESSION G1: SYMPTOM MANAGEMENT -3 CHAIR: LEANNE MONTEROSSO, AUSTRALIA
3.00pm – 3.15pm
Ballroom BC
OE-66. The Efficacy of Empowerment based on Education Program on the Prevention of Febrile Neutropenia WAI CHI MAK, CHINA
3.15pm – 3.30pm
OE-67. Improving Cancer Symptom Management through Knowledge Translation: Implications for Nursing Practice DENISE BRYANT-LUKOSIUS, CANADA
3.30pm – 3.45pm
OE-68. Oncodermatologic Adverse Events (DAE): Driving Nursing Practice with CREAM Principles KATHRYN CICCOLINI, USA
3.45pm – 4.00pm
OE-69. Self-Identification and Management of Hand-Food Syndrome (HFS): Effect of a Teaching Program KALAIVANI MURUGAN, INDIA
4.00pm – 4.15pm
OE-70. Evaluating Nurses’ Experience of Caring for Patients with Cancer and Dementia CAROLE FARRELL, UNITED KINGDOM
www.isncc.org
29
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Conference Day 2: Tuesday 6 September 2016 3.00pm – 4.20pm
Concurrent Sessions
CONCURRENT SESSION G2: FAMILY & CAREGIVER CHAIR: ANDREW DIMECH, UNITED KINGDOM
3.00pm – 3.15pm
Ballroom A
OE-71. Video Modelling to Provide Support for Bereaved Caregivers of an Advanced Cancer Patient LORRAINE HOLTSLANDER, CANADA
3.15pm – 3.30pm
OE-72. Caregivers’ Burden of Patients with Neuroendocrine Neoplasms and Related Factors LIYAN ZHANG, CHINA
3.30pm – 3.45pm
OE-73. Keeping Parents’ Hope Possible: What does holistic family nursing care really look like? MERIDITH BURLES, CANADA
3.45pm – 4.00pm
OE-75. The Supportive Care Needs of Parents of Pediatric Oncology Patients in Hong Kong WINNIE PY TANG, CHINA
3.10pm – 4.00pm
Concurrent Sessions
MANDARIN CONCURRENT SESSION G3: RAPID FIRE CHAIR: WINNIE SO, CHINA
3.00pm – 3.10pm
Sung
RF-M-2. Cancer Patient’s Stress Appraisals and Depression: Implications for Providing Social Support XIAONA QI, CHINA
3.10pm – 3.20pm
RF-M-8. Effect of Intervention on Self-Image of Breast Cancer Patients after Breast-Conserving Surgery QING WANG, CHINA
3.20pm – 3.30pm
RF-M-11. The Establishment and Application of Safe Maintenance Mode for Patients with PICC in Xinjiang Province LING CHEN, CHINA
3.30pm – 3.40pm
RF-M-12. Risk Factors and Prevention Strategy of Malposition of Peripherally Inserted Central Catheter SHAOYONG WU, CHINA
3.40pm – 3.50pm
RF-M-14. Study on the Relationship Between Job Fatigue and Job Satisfaction of Cancer Nurses YANHUA TENG, CHINA
30
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Conference Day 2: Tuesday 6 September 2016 3.00pm – 4.20pm
Concurrent Sessions
INSTRUCTIONAL SESSION G4: CROSS SECTIONAL CARE DELIVERY ACROSS CANCER PATIENT DISEASE JOURNEY IN HONG KONG SETTING
Ching
CHAIR: SIN TING WONG, CHINA
SPEAKERS: LAI LOR NG, CHINA, WAI MAN LING, CHINA, YIN PING CHOY, CHINA AND ANNDA LUM, CHINA
Learning Objectives: 1. Discussing different approaches to and strategies for enhancing collaboration in cancer care, streamlining the care and service delivery during different transition periods of patient’s cancer journey 2. Overseas participants can get a better understanding on the characteristics of cancer care in the public healthcare system of Hong Kong, which may be different with their own countries. 4.20pm – 4.40pm
Coffee/Tea break with Exhibits and Poster Session 2
4.40pm – 5.30pm
DISTINGUISHED MERIT AWARD
Tang & Tang Foyer Sung
CHAIR: STELLA BIALOUS, USA
Reflections Across 4 Decades in Cancer Nursing – A Journey from Human to Population Perspectives SPEAKER: SANCHIA ARANDA, PRESIDENT ELECT UICC, AUSTRALIA
5.30pm – 6:30pm
POSTER SESSION 2 MOVE OUT
Tang & Tang Foyer
6.30pm – 8.30pm
POSTER SESSION 3 MOVE IN
Tang & Tang Foyer
5.40pm – 6.30pm
ISNCC GENERAL BUSINESS MEETING ISNCC members – join us to learn more about ISNCC’s activities and leadership!
Sung
6.45pm – 8.30pm
MEMBER COUNCIL DINNER MEETING*
Ming
8.30pm – 9.30pm
PRESIDENT’S SOCIAL*
Please have your poster displayed before 7.30am on Wednesday, 7 September.
Ming Terrace
Conference Day 3: Wednesday 7 September 2016 Pastries and fruit provided.
Ballroom Foyer
7.00am – 5.00pm
Conference Registration Open
7.00am – 3.00pm
Speaker Services Open
7.00am – 8.00am
ISNCC CORPORATE AND PHILANTHROPIC DEVELOPMENT COMMITTEE MEETING
www.isncc.org
Tang Foyer Group Lounge Business Centre
* By invitation only ***Pre-registration required
31
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Conference Day 3: Wednesday 7 September 2016 8.00am – 9.00am
PLENARY SESSION IV European Oncology Nursing Society (EONS) International Partner Joint Session
Ballroom BC
CHAIR: ANDREAS CHARALAMBOUS, CYPRUS
Enhancing Recognition of the Nursing Contribution to Cancer Care: Current Challenges and Solutions in Europe SPEAKER: MARY WELLS, UNITED KINGDOM
Learning Objectives: 1. To reflect on current challenges facing cancer nurses and cancer nursing 2. To consider the evidence on the contribution that cancer nurses make to improving cancer care 3. To learn about the work of the European Oncology Nursing Society in addressing current challenges and recognising cancer nursing across Europe 9.10am – 10.30am Concurrent Sessions
CONCURRENT SESSION H1: PSYCHOSOCIAL CARE CHAIR: MYRNA MCLAUGHLIN-ANDERSON, PANAMA
9.10am – 9.25am
Ballroom BC
OE-76. Cancer Diagnosis: Impact on Psychological Status of Indian Women with Breast Cancer SHEJILA CHILLAKUNNEL HUSSAIN RAWTHER, INDIA
9.25am – 9.40am
OE-77. Predictors of Self-Reported Satisfaction and Outcomes of Cancer Council WA Counselling Program LESLEY MILLAR, AUSTRALIA
9.50am – 9.55am
OE-78. Body Image and Sexuality Concerns of Patients with Recurrent Head and Neck Cancer BETHANY RHOTEN, USA
9.55am – 10.10am
OE-79. Psychological Distress among Elderly Patients with Cancer YONGXIA SONG, CHINA
10.10am – 10.25am
OE-80. A Longitudinal Study of Body Image in Young Breast Cancer Patients During Postoperative Chemotherapy HOU SHENGQUN, CHINA
9.10am – 10.30am Concurrent Sessions
CONCURRENT SESSION H2: INNOVATIONS CHAIR: ANDREW DIMECH, UNITED KINGDOM
9.10am – 9.25am
Ballroom A
OE-81. Problem Solving for Better Health-Nursing: Application to a Cancer Hospital in China AIRONG LU, CHINA
9.25am – 9.40am
OE-82. The Contribution of Prostate Cancer Specialist Nurses: Perspectives of Clinicians JULIE SYKES, AUSTRALIA
9.50am – 9.55am
OE-83. Oral Chemotherapy: Enhancing Nursing Practice in Four Latin American Countries TRACY TRUANT, CANADA
32
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Conference Day 3: Wednesday 7 September 2016 9.10am – 10.30am
9.55am – 10.10am
Concurrent Sessions
OE-84. Development of a Pilot Randomised Controlled Trial: Lymphoma Nurse-Led Model of Survivorship Care LEANNE MONTEROSSO, AUSTRALIA
10.10am – 10.25am
OE-85. Plastics and Breast Reconstruction Advanced Nurse Practitioner: Impact of the Role in a Cancer Centre JON KNOX, UNITED KINGDOM
9.10am – 10.30am Concurrent Sessions
Sung
CONCURRENT SESSION H3: SURVIVORSHIP -2 CHAIR: MYRNA DOUMIT, LEBANON
9.10am – 9.25am
OE-86. Activities of Daily Living Problems in Elderly Cancer Survivors ELLEN KARINE GROV, NORWAY
9.25am – 9.40am
OE-87. Development of a Survivorship Care Plan and Treatment Summary for Lymphoma Survivors LEANNE MONTEROSSO, AUSTRALIA
9.50am – 9.55am
OE-88. Combining Manual Lymph Drainage with Physical Exercise Effectively Prevents Axillary Web Syndrome ZHU XIN, CHINA
9.55am – 10.10am
OE-89. Relationships among Fatigue, Depressive Symptoms, and Quality of Life in Childhood Cancer Survivors HO CHEUNG WILLIAM LI, CHINA
10.10am – 10.25am
OE-90. The First Two Years after Colorectal Cancer Treatment: UK Colorectal Wellbeing (CREW) Cohort Study JANE WINTER, UNITED KINGDOM
9.10am – 10.30am Concurrent Sessions
INSTRUCTIONAL SESSION H4: IMPLEMENTING INTERNATIONAL SEPSIS BEST PRACTICES FOR CANCER PATIENTS: A GLOBAL PERSPECTIVE
Ching
CHAIR: BRENDA SHELTON, USA
SPEAKERS: ROSARIO REYES, SINGAPORE AND MAHMOUD ABDUL RAHIM HASAN, UNITED ARAB EMIRATES, BRENDA SHELTON, USA
Learning Objectives: 1. Describe key elements of the recommended “Surviving Sepsis bundled interventions”. 2. Discuss the challenges that these international best practices present in caring for cancer patients and strategies that clinicians have used to overcome barriers to their implementation. 10.20am – 2.00pm
EXHIBITS AND POSTER SESSION 3 OPEN
10.30am – 10.50am Coffee/Tea Break with Exhibits and Poster Session 2
www.isncc.org
Tang & Tang Foyer Tang & Tang Foyer
33
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Conference Day 3: Wednesday 7 September 2016 CONCURRENT SESSION I1: SYMPTOM MANAGEMENT -4 10.50am – 12.05pm CHAIR: KARIS CHENG, SINGAPORE Concurrent Sessions
10.50am – 11.05am
Ballroom BC
OE-91. Nurses’ Attitudes and Practices About Patient Activation and Self-Management Support in Cancer Care DENISE BRYANT-LUKOSIUS, CANADA
11.05am – 11.20am
OE-92. Cancer-Related Fatigue in NSCLC Patients Treated with Transcutaneous Electrical Acupoint Stimulation YIFAN WU, CHINA
11.20am – 11.35am
OE-93. Patients with Chemotherapy-Induced Peripheral Neuropathy: A Qualitative Research of Symptom Experience YUE WANG, CHINA
11.35am – 11.50am
OE-94. Chemotherapy-Induced Peripheral Neuropathy (CIPN). Incidence & Assessment Evaluation EMMA LACEY, AUSTRALIA
11.50am – 12.05pm
OE-95. Knowledge, Attitude and Practice on Chemotherapy-Induced Peripheral Neuropathy among Oncology Nurses YUE WANG, CHINA
CONCURRENT SESSION I2: HEALTH SYSTEMS 10.50am – 12.10pm CHAIR: SUSANNE CRUICKSHANK, UNITED KINGDOM Concurrent Sessions
10.50am – 11.05am
Ballroom A
OE-96. Collecting Accurate Data within an Adolescent and Young Adult Cancer Service; is there a need? DI SAWARD, AUSTRALIA
11.05am – 11.20am
OE-97. ISNCC Collaborative on Cervical Cancer Screening in Latin America CATHERINE JOHNSON, AUSTRALIA
11.20am – 11.35am
OE-98. An Interpretive Description of Internet Cancer Information Use by Newly Diagnosed Individuals KRISTEN HAASE, CANADA
11.35am – 11.50am
OE-100. The Effectiveness of an Integrated Palliative Care Program for Patients with Cancer in China XIANGYU LIU, CHINA
CONCURRENT SESSION I3: RAPID FIRE – ENGLISH 10.50am – 12.10pm CHAIR: MEGAN ROGERS, AUSTRALIA
Sung
Concurrent Sessions
11.00am – 11.10am
RF-E-25. Ipsilateral Arm Usage for Chemotherapy in Breast Cancer? ELAINE LENNAN, UNITED KINGDOM
11.10am – 11.20am
RF-E-26. The Control Study Between Follow-Up Based on the Cloud Platform with Traditional Telephone Follow-Up YU LIU, CHINA
34
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Conference Day 3: Wednesday 7 September 2016 10.50am – 12.10pm
11.20am – 11.30am
Concurrent Sessions
RF-E-28. Building Palliative Care Capacity in Alliance of ELNEC and National Palliative Care Program Panama MYRNA MCLAUGHLIN DE ANDERSON, PANAMA
11.30am – 11.40am
RF-E-29. Views and Attitudes Towards Using Venipuncture and Cannulation After Breast Surgery ELAINE LENNAN, UNITED KINGDOM
11.40am – 11.50am
RF-E-30. Lymphedema and Fibrosis in Head and Neck Cancer Patients SHEILA RIDNER, USA Ching
CONCURRENT SESSION I4: DECISION-MAKING 10.50am - 11.50am CHAIR: SUZANNE SO-SHAN MAK, CHINA Concurrent Sessions
10.50am – 11.05am
OE-101. Women’s Perception, Evaluation, and Satisfaction from Breast Reconstruction VARDA SWAGER, ISRAEL
11.05am – 11.20am
OE-102. Recurrent Head and Neck Cancer: Patient Decision-Making BETHANY RHOTEN, USA
11.20am – 11.35am
OE-103. Cancer Patients’ Needs in the End-of-Life Period: From the Perspective of Chinese Family Members JINGYU XU, CHINA
11.35am – 11.50am
OE-104. The Efficacy of Intervention on DNR Decision Making in Cancer Patients: A Systematic Review CHEN LI TING, TAIWAN
12.20pm – 1.20pm
CORPORATE LUNCH SYMPOSIUM (OPEN TO ALL REGISTERED DELEGATES) Supported by Merck
Ballroom BC
Putting the Nurse at the Center of CINV Management SPEAKERS:
Alex Molasiotis (China), Chair Professor of Nursing & Head of School, Hong Kong Polytechnic University Alexandre Chan, Pharm.D., MPH, FCCP, BCPS, BCOP Deputy Head and Associate Professor, Department of Pharmacy, National University of Singapore, Associate Professor, Duke-NUS Medical School, Specialist Pharmacist (Oncology Pharmacy), National Cancer Center Singapore, Board Member, Multinational Association of Supportive Care in Cancer, Associate Editor, Journal of Oncology Pharmacy Practice
1.20pm – 1.50pm
www.isncc.org
Coffee/Tea Break with Exhibits and Poster Session 3
Tang & Tang Foyer
35
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Conference Day 3: Wednesday 7 September 2016 1.50pm – 2.50pm
PLENARY SESSION V: NURSING LEADERSHIP IN MULTIDISCIPLINARY CANCER CARE: ROLES AND CHALLENGES Asian Oncology Nursing Society (AONS) International Partner Joint Session
Ballroom BC
CHAIR: KEUI-RU CHOU, TAIWAN
Leading Multidisciplinary Cancer and Palliative Care Research: The Role of Nurses SPEAKER: CARMEN CHAN, CHINA
Role of Nursing Leadership in Integrating Clinical Nurse Specialists in Cancer Care SPEAKER: MEERA ACHREKER, INDIA
Nursing Leadership to Affect Policy Change for Cancer Care SPEAKER: KYUNG HEE LIM, KOREA
Learning objectives: 1. Discuss the importance of nursing leadership in multidisciplinary cancer care 2. Discuss the roles of nursing leadership in integrating clinical nurse specialist in cancer care 3. Discuss roles of nurses in leading multidisciplinary cancer and palliative care research 4. Discuss how nursing leadership effect policy change for cancer care. 5. Identify challenges encountered by oncology nurses when they are leading multidisciplinary cancer and palliative research / services and discuss how to overcome these challenges 2.00pm – 5.00pm
3.00pm – 4.00pm
EXHIBITS AND POSTER SESSION 3 MOVE OUT Poster Session 3 Move Out: 2.00pm-3.00pm Exhibitors Move Out: 2.00pm-5.00pm
Ballroom BC
OFFICIAL CLOSING 3.00pm – 3.30pm
Tang & Tang Foyer
Presidential Address and Presentation of the ISNCC Past Presidents’ Award SPEAKER: STELLA BIALOUS, USA
3.30pm – 3.40pm
ISNCC Poster Awards
SPEAKER: LINDA KREBS, USA
3.40pm – 3.45pm
Presentation for ICCN 2017 SPEAKER: LINDA KREBS, USA
3.45pm – 4.00pm
Closing Celebration with Chinese Drum Show SPEAKER: STELLA BIALOUS, USA
36
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
POSTER ABSTRACT LISTINGS Poster Session 1 Program Abstract Title ID
Presenter(s)
Country
P1-1
NURSING EFFECT STUDY OF HOSPICE CARE IN PATIENTS WITH ADVANCED PANCREATIC CANCER
Xia Liu
China
P1-2
EVIDENCED BASED ON PATIENTS WITH TERMINAL ILLNESS COMFORT CARE PROGRAMS
Wan Chiu
Taiwan
P1-3
SPIRITUALITY AMONG PARENTS OF CHILDREN WITH CANCER AT AUBMC
Myrna Doumit
Lebanon
P1-5
EMOTIONAL ISSUES FOR END-OF-LIFE CANCER PATIENTS AT HOME
Ayumi Kyota
Japan
P1-6
DEVELOPING CLINICAL INDICATORS FOR PALLIATIVE CARE OF PEDIATRIC CANCER PATIENTS
Carmen WH Chan
China
P1-8
APPLICATION OF NEURO-LINGUISTIC PROGRAMMING IN PALLIATIVE CARE FOR CANCER PATIENTS
Xin Peng
China
P1-10
STUDENT’S UNDERSTANDING OF SUPPORT FOR PERSONS CHOOSING HOME-BASED END-OF-LIFE CARE
Junko Kakeya
Japan
P1-11
A NURSING EXPERIENCE ON DEATH ANXIETY OF A PATIENT SUFFERING FROM TERMINAL HEPATOMA AT FIRST VISIT
Yi-chen Wang
Taiwan
P1-13
PARTNERSHIPS IN PALLIATIVE CARE: REVIEW OF A MULTI- Helen Langhorn DISCIPLINARY OUTPATIENT SERVICE.
United Kingdom
P1-14
PALLIATIVE CARE NURSING IN OMAN; A COUNTRY’S JOURNEY
Manal Al-Zadjali
Oman
P1-15
STUDY ON BUILDING A COMPETENCY MODEL FOR NURSES CARING FOR THE TERMINAL CANCER PATIENTS
Miyuki Hoshina
Japan
P1-16
DEVELOPMENT AND VALIDATION OF THE SELF-CARE AGENCY SCALE OF CANCER PATIENTS IN THERAPY
Kumiko Yoshida
Japan
P1-17
THE EFFECT OF SALIVATION STIMULATION METHOD FOR Jeong Sook Park XEROSTOMIA OF COLOPECTAL CANCER PATIENTS
South Korea
P1-18
DEVELOPMENT OF THE COMPREHENSIVE ASSESSMENT SCALE FOR CIPN IN SURVIVORS OF CANCER
Kiyoko Kanda
Japan
P1-19
SYMPTOMS AND QUALITY OF LIFE OF ESOPHAGEAL CANCER PATIENTS PRE- AND POST-SURGERY
Yumi Watanabe
Japan
P1-20
AN ILL BLOKE’S BLOG: THE USE OF BLOGGING AS A COPING STRATEGY FOR BURKITT’S LYMPHOMA
Bethany Hanan
United Kingdom
P1-21
EFFICACY OF OXYCOTIN IN THE TREATMENT OF SEVERE CANCER PAIN BY RECTAL ADMINISTRATION
Yanglin Zhang
China
P1-22
LATE EFFECTS OF PARTICLE THERAPY EXPERIENCED BY SURVIVORS WITH HEAD AND NECK CANCER
Asuka Ebisutani
Japan
www.isncc.org
37
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Program Abstract Title ID
38
Presenter(s)
Country
P1-23
DEVELOPING SIMULATION CASES TO EVALUATE SEVERITY Rumi Maeda OF ACUTE/CHRONIC SKIN GRAFT VERSUS HOST DISEASE
Japan
P1-24
DEVELOPMENT OF FIRST YEAR PRACTICE TOOL FOR HEAD AND NECK CANCER SURGICAL ONCOLOGY RNS
Ji Eyun Park
South Korea
P1-25
THE IMPLEMENTATION AND PROMOTION FACTORS OF THE DYSPNEA CARE IN PALLIATIVE CARE UNITS ACROSS JAPAN.
Ayumi Sugimura
Japan
P1-26
LOWER ERROR RATE OF SKIN SELF-CARE IN PATIENT RECEIVING RADIATION THERAPY
Ya-Hsueh Tseng
Taiwan
P1-27
DEVELOPMENT OF APPLICATION FOR REGARDING TO PERIPHERAL NERVE DISORDER CAUSED BY CANCER THERAPY
Kazuko Ishida
Japan
P1-28
CURRENT STATE OF ACTIVITIES AND ROLES OF CERTIFIED NURSES IN CANCER CHEMOTHERAPY NURSING IN JAPAN
Saori Miura
Japan
P1-29
A PILOT PROJECT TO IMPROVE THE MANAGEMENT OF CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA
Tak Kei Liu
China
P1-30
USING A MULTICULTURAL TRANSLATION TEAM TO TRANSLATE AN ENGLISH INSTRUMENT TO MANDARIN
Jia-Wen Guo
USA
P1-33
EFFECTS OF CHEMOTHERAPY-INDUCED ALOPECIA ON MALE CANCER PATIENTS
Keiko Mori
Japan
P1-34
CHEMOTHERAPY- INDUCED PAIN AND NEUROPATHY IN BREAST CANCER PATIENTS
Boonyard Munaudsa
Thailand
P1-35
CASE MANAGEMENT MODEL IS APPLIED TO ANALYZE THE EFFECTIVENESS OF INTERVENTION FOR CANCER PATIENTS
Chang Chan
Taiwan
P1-36
CHANGES IN MENOPAUSAL SYMPTOMS IN PREMENOPAUSAL BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY
Yuko Arahori
Japan
P1-37
CHANGES OF EATING BEHAVIOR, PHYSICAL SYMPTOM, Kayo Toyofuku AND SELF-CARE ABILITY IN POST-GASTRECTOMY PATIENTS
Japan
P1-38
MEDICATION ADHERENCE IN COLORECTAL CANCER PATIENTS WITH ADJUVANT CAPECITABINE CHEMOTHERAPY
Yuki Nagamatsu
Japan
P1-39
ORAL HEALTH BEHAVIORS AND ORAL ISSUES THAT OCCUR IN CANCER OUTPATIENTS OF PALLIATIVE CARE DEPARTMENT
Hiromi Seto
Japan
P1-40
CONCEPTUAL ANALYSIS OF A FEELING OF DYSPNEA AMONG CANCER PATIENTS
Kiyoko Kanda
Japan
P1-41
THE INFLUENCE OF CHEMOTHERAPY INDUCED ALOPECIA ON THE ROLE OF MOTHERS IN BREAST CANCER PATIENTS
Kayo Inoue
Japan
P1-42
EFFECTS OF LOCAL HYPERTHERMIA ON PHYSIOLOGICAL Rieko Izukura AND SUBJECTIVE RESPONSES IN CANCER PATIENTS
Japan
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Program Abstract Title ID
Presenter(s)
Country
P1-43
EFFECTIVENESS OF MOISTURIZING BARRIER CREAM DURING EXTERNAL BEAM RADIATION THERAPY
Anuttra Wunnasaweg
Thailand
P1-46
THE EFFECT OF MULTIDIMENSIONAL PATHWAY HEALTH EDUCATION MODE IN NURSING OF RADIATION ESOPHAGITIS
Yunxia Zhu
China
P1-47
NURSING EXPERIENCE OF AN END STAGE BREAST CANCER PATIENT WITH CHEMOTHERAPY INDUCED LEUKOPENIA
Kai-Chun Chen
Taiwan
P1-48
SPECIALIST NURSE CLINIC AND MANAGEMENT PROGRAM FOR BREAST CANCER PATIENT IN PRINCE OF WALES HOSPITAL
Yuk King Hung
China
P1-49
HOW DO PATIENTS WITH HEAD AND NECK CANCER PERCEIVE MANAGEMENT OF ORAL MUCOSITIS PAIN INDUCED BY CRT?
Mariko Koike
Japan
P1-51
NURSING OF SMALL BOWEL GIST COMPLICATED WITH MULTIPLE METASTASIS AND ABDOMINAL WALL PERFORATION
Kai-Chun Chen
Taiwan
P1-52
TRANSLATION AND VALIDATION OF THE INDONESIA VERSION OF MEMORIAL SYMPTOM ASSESSMENT SCALE (MSAS)
Haryani Haryani
Taiwan
P1-53
PHYSICIANS’ PERCEPTION OF PAIN MANAGEMENT OF MUCOSITIS ASSOCIATED WITH CRT IN HEAD AND NECK CANCER
Harue Arao
Japan
P1-54
CANCER AND OPPORTUNISTIC INFECTIONS AMONG THE PEOPLE LIVING WITH AIDS ON ART IN EASTERN NEPAL
Dr. Ram Mehta
Nepal
P1-55
NEUROENDOCRINE CANCERS: THE NEED TO RAISE GLOBAL AWARENESS
Megan Rogers
Australia
P1-56
THE LONG-TERM SYMPTOMS AND SELF-EFFICACY OF Kimiko Miyata PATIENTS WITH THORACIC ESOPHAGEAL CANCER AFTER SURGERY
Japan
Poster Session 2 Program Abstract Title ID
Presenter(s)
Country
P2-1
IMMUNOTHERAPY IN CANCER TREATMENT
Haihong Cai
USA
P2-2
THE EFFECTS OF SERVICE BY ONCOLOGY NURSE CASE MANAGERS ON CANCER PATIENTS’ SATISFACTION IMPROVEMENT
Mei-ling Shih
Taiwan
P2-3
DESCRIBING MEN’S PERSPECTIVES ABOUT ACTIVE SURVEILLANCE
Margaret Fitch
Canada
P2-4
IMPACT OF ONCOTYPE DX TESTING FOR THE MANAGEMENT OF PATIENTS WITH INTERMEDIATE RISK BREAST CANCER
Helen Roe
United Kingdom
www.isncc.org
39
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Program Abstract Title ID
40
Presenter(s)
Country
P2-5
DECISION MAKING EXPERIENCE ON BREAST RECONSTRUCTION OF WOMEN WITH BREAST CANCER IN KOREA
Myungsun Yi
South Korea
P2-6
THE DECISION-MAKING PROCESS ON GOING THE ACTIVE TREATMENT OF ADVANCED PANCREATIC CANCER PATIENTS
Kanako Naito
Japan
P2-7
STATE OF NURSING SUPPORT FOR DECISION-MAKING BY CANCER PATIENTS IN JAPAN
Hisako Nakao
Japan
P2-8
OMAN CANCER ASSOCIATION; THE ROLE OF AN NGO IN PROMOTING HEALTH AND PREVENTING CANCER
Manal Al-Zadjali
Oman
P2-10
DEVELOPMENT OF “GUIDELINES FOR SAFE HANDLING OF CANCER CHEMOTHERAPY DRUGS” IN JAPAN.
Kazue Hirai
Japan
P2-12
SURVEYS OF CURRENT SITUATION OF MENTAL HEALTH AND JOB BURNOUT OF NURSES WORKING IN ONCOLOGY UNIT
Shan Liu
China
P2-14
ACCURACY OF EVALUATING ACUTE/CHRONIC SKIN GVHD USING COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS
Rumi Maeda
Japan
P2-15
PREVENTIVE EDUCATION OF ANTICANCER AGENT EXPOSURE FOR PATIENTS AND THEIR FAMILY
Michiko Yuki
Japan
P2-16
EDUCATING SURGICAL WARD NUESES ON COMMUNICATING WITH TERMINALLY ILL CANCER PATIENTS ABOUT DEATH
Keiko Ban
Japan
P2-17
MACMILLAN ACUTE ONCOLOGY SERVICE (MAOS):IMPROVING UNSCHEDULED CARE IN THE MANAGEMENT OF VTE
Anila Varghese
United Kingdom
P2-18
INTRODUCTION OF THE GASTRO REFERRAL PATHWAY (GRP): MAXIMISING EARLY CANCER NURSE COORDINATION
Michelle Davies
Australia
P2-20
EFFECTS OF HUMANISTIC CARE ON THE SELF-CARE ABILITY OF POSTOPERATIVE PATIENTS OF BREAST CANCER
Di Wei
China
P2-21
EXTENDING THE INTERVAL FLUSHING FOR PORT-ACATHETER IN HEMATOLOGICAL CANCER PATIENTS
Mei-Bih Chen
Taiwan
P2-22
THE EFFECT OF ADDING “COMFORT CARE COURSE” IN NEW NURSE’ PRE-EMPLOYMENT TRAINING PROGRAM.
Shu-Hui Liu
Taiwan
P2-25
APPLICATION OF FAST TRACK SURGERY IN PERIOPERATION NURSING OF COLORECTAL PATIENTS
Hui Zhu
China
P2-26
APPLICATION OF CONTINUOUS MEDICAL SERVICE BASED ON NETWORK IN PATIENTS WITH PICC DURING DISCHARGE
Ping Gong
China
P2-27
THE EFFECT OF NURSE-LED PEER DISCUSSION GROUP IN Xiao Xin COLORECTAL CANCER PATIENTS EDUCATION
China
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Program Abstract Title ID
Presenter(s)
Country
Hui-Fang Tung
Taiwan
P2-28
EFFECTIVENESS OF NURSE CASE MANAGEMENT COMPARED WITH USUAL CARE IN CANCER PATIENTS IN TAIWAN
P2-29
ESTABLISHMENT OF THE JEJUNOSTOMY CLINICAL CARE Yu-Chu Pai GUIDELINE FOR ESOPHAGEAL CANCER PATIENTS
Taiwan
P2-31
THE IMPORTANCE OF SUPPORTIVE CARE NEEDS AND RELATED FACTORS AMONG WOMEN WITH GYNECOLOGIC
Yue Qu
China
P2-33
IS IT TIME TO IMPLEMENT 12-HOUR SHIFT FOR TAIWAN NURSES?
Li-Ting Wang
Taiwan
P2-36
RELATIONSHIPS AMONG FATIGUE, CANCER WORRY AND Ya-Lan Chang QUALITY OF LIFE IN ORAL CANCERS PATIENTS
Taiwan
P2-37
SURVEY OF THE SAFE HANDLING OF HAZARDOUS DRUGS BY NURSES IN JAPAN
Japan
P2-38
THE EFFECTIVENESS OF CLOSED-SYSTEM DRUG TRANSFER Ming-Ying Hong DEVICE FOR CHEMOTHERAPY ADMINISTRATION
Taiwan
P2-39
RESPONDING TO TELEPHONE PATIENT REPORTED CHANGE IN CLINICAL STATUS: POLICY AND ALGORITHM DEVELOPMENT
Catherine Barratt
Australia
P2-42
NURSING CARE AND SAFETY FOR OUTPATIENT WITH CT GUIDED PERCUTANEOUS TRANSTHORACIC NEEDLE BIOPSY (PTNB)
Wu Tsumei
Taiwan
P2-43
EFFECT OF AN INPATIENT NURSING RISK EARLY WARNING AND CONTROL SYSTEM IN SHANGHAI
Qian Wu
China
P2-46
USING OSCE INCREASE THE COMPLETENESS OF PHYSICAL EXAMINATION OF ONCOLOGY NURSE PRACTITIONER
Chiao Hui Lin
Taiwan
P2-47
EFFECTIVENESS OF 24 HOUR LIFELINE SERVICE FOR HEPATOCELLULAR CARCINOMA PATIENTS
Chen Yi
Taiwan
P2-48
IDENTIFYING SERVICE GAPS IN PROSTATE CANCER PATIENTS
Junko Kakeya
Japan
P2-50
IMPROVEMENT PROJECT FOR REDUCING INCIDENCE OF Yun-Hsuan Shih FALLS OF ONCOLOGY PATIENTS BY FALL-RISK RATING
Taiwan
P2-51
FALL PREVENTION PROJECT BY SMALL TEAM APPROACH Shuk Yee Lam TO ENHANCE PATIENT SAFETY AT CLINICAL ONCOLOGY WARD
China
P2-52
EMPOWERING SPANISH SPEAKING CANCER PATIENTS ON CANCER PAIN VIA AN INTERACTIVE PAIN EDUCATION PROGRAM
Gloria Juarez
USA
P2-53
THE EVALUATION OF MUSIC INTERVENTION FOR CANCER PATIENTS’ ANXIETY, DEPRESSION, PAIN, AND FATIGUE
Kuei-Ru Chou
Taiwan
P2-55
PREDICTORS OF VISITING EMERGENCY ROOM IN HEMATO-ONCOLOGIC PATIENTS
Jeong Sook Park
South Korea
www.isncc.org
Keiko Iino
41
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Program Abstract Title ID
Presenter(s)
Country
Chika Minowa
Japan
P2-56
AUTOGENIC TRAINING MAY ENHANCE THE IMMUNE FUNCTION OF THE ORAL CAVITY
P2-57
THE INFLUENCE OF THE MODE OF SBAR COMMUNICATION Weiping Li IN NURSE-DOCTOR COLLABORATION MODE
China
P2-58
EVOLVING TECHNOLOGY THAT PROMOTES PATIENT INDEPENDENCE: EXAMPLE FROM A CHEMOTHERAPY UNIT IN THE UK
Kate Edridge
United Kingdom
P2-59
A CLINICAL NURSING PATHWAY IN THE STANDARD MANAGEMENT OF PATIENTS WITH RADIODERMATITIS
Hui Yang
China
P2-61
WORK STRESS AMONG HAEMATO-ONCOLOGY & BONE MARROW TRANSPLANT NURSES IN NORTH INDIA
Sangeetha Samuel
India
Presenter(s)
Country
Poster Session 3 Program Abstract Title ID
42
P3-1
RESILIENCE AND COPING STRATEGIES INFLUENCING THE QUALITY OF LIFE IN PATIENTS WITH BRAIN TUMOR
Shu-Yuan Liang
Taiwan
P3-2
EFFECTS OF APPRAISALS OF ILLNESS ON ANXIETY AND QUALITY OF LIFE IN COUPLES OF PROSTATE CANCER
Ching-Hui Chien
Taiwan
P3-4
PRACTICE AND EXPERIENCE OF NURSES COMBINE PHARMACISTS ABOUT HEALTH EDUCATION IN PATIENTS WITH PAIN
Baoling Li
China
P3-5
NURSING EXPERIENCE CARING FOR A PATIENT WITH BONE METASTASIS FROM LUNG CANCER
Shin-Na Lee
Taiwan
P3-6
RELIABILITY AND VALIDITY OF A JAPANESE VERSION OF THE QUALITY OF LIFE INDEX IN CANCER PATIENTS
Michiyo Mizuno
Japan
P3-7
THE PROTECTIVE FACTORS OF DEMORALIZATION IN CANCER PATIENTS IN TAIWAN
Yu Chi Li
Taiwan
P3-9
SLEEP QUALITY AND ITS IMPACT ON THE PRIMARY CAREGIVER OF PATIENTS WITH GASTRIC CANCER
Nan Hao
China
P3-11
PARENTAL SUPPORT: EVALUATING A THEORY-BASED HOPE INTERVENTION
Meridith Burles and Canada Lorraine Holtslander
P3-14
DEVELOPMENT OF LEARNING MATERIALS ON CANCER FAMILY CARE FOR JAPANESE GENERAL WARD NURSES
Satoko Chou
Japan
P3-16
SLEEP DISTURBANCE IN HOSPITALIZED RECIPIENTS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Rutuja Dandekar
India
P3-17
VALIDATION OF THE CHINESE VERSION GLOVER NILSSON SMOKING BEHAVIOR QUESTIONNAIRE IN TAIWANESE SMOKERS
Hsi-Ling Peng
Taiwan
P3-18
IMPLEMENTATION A CENTRAL LINE CARE BUNDLE IN HOSPITALIZED ONCOLOGY PATIENT
Sheung Ling Chan
China
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
Program Abstract Title ID
Presenter(s)
Country
P3-19
EVIDENCE FOR THE ASSOCIATION OF GLYCEMIC INDEX AND CANCER RISK
Carmen WH Chan
China
P3-20
OVERVIEW OF JSCN/JSMO/JASPO JOINT GUIDELINES FOR SAFE HANDLING OF CANCER CHEMOTHERAPY DRUGS IN JAPAN
Kiyoko Kanda
Japan
P3-21
SMOKING CESSATION COUNSELING BEHAVIORS IN TOBACCO CONTROL SEED INSTRUCTORS IN TAIWAN
Hsiu-Wen Tsai
Taiwan
P3-23
DELAY OF HELP SEEKING BEHAVIOR IN JAPANESE BREAST CANCER PATIENTS.
Mariko Oshiro
Japan
P3-24
A STUDY OF DEMOGRAPHIC FACTOR ON RISK OF BREAST CANCER
Tso-Ying Lee
Taiwan
P3-26
FACTORS THAT INFLUENCE PSYCHOLOGICAL DISTRESS AMONG CANCER SURVIVORS
Isako Ueta
Japan
P3-27
TEXT MINING ANALYSIS OF POST-DISCHARGE OF ELDERLY PATIENTS RECEIVING ORAL RADIOACTIVE IODINE THERAPY
Junko Yoshimura
Japan
P3-28
A STUDY ON A NURSING INTERVENTION TO INCREASE FULFILLMENT IN THE FIRST RECURRENCE BREAST CANCER
Naomi Ota
Japan
P3-29
MOOD STATE PARAMETERS IN PATIENTS BEFORE ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP)
Yoko Miyoshi
Japan
P3-30
KING’S HEALTH QUESTIONNAIRE (KHQ) AFTER ROBOTASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP)
Yoko Miyoshi
Japan
P3-31
EXPERIENCE ON PATIENTS WITH CANCER OF UNKNOWN Kyoko Ishida PRIMARY: FROM ONSET OF SYMPTOMS TO INITIAL TREATMENT
Japan
P3-32
CHANGES OF UNMET SUPPORTIVE CARE NEEDS IN KOREAN WOMEN WITH NEWLY DIAGNOSED BREAST CANCER
Jin-Hee Park
South Korea
P3-33
HOPE AND COPING BEHAVIORS IN LUNG CANCER PATIENTS WITH POST-OPERATIVE ADJUVANT THERAPY
Takae Bando
Japan
P3-34
PATIENT EDUCATION IN ENHANCED RECOVERY PROTOCOLS IN CANCER SURGERY – A LITERATURE REVIEW
Anna-Maria Hiltunen
Finland
P3-36
PSYCHOLOGICAL SUPPORT AND THE HOPE OF THE LUNG CANCER PATIENTS RECEIVING CHEMOTHERAPY
Hiroko Ota
Japan
P3-39
PSYCHOLOGICAL EXEPERIENCES AFTER LRP WHO HAVE SUFFERED FROM UI
Haiqin Hu
China
P3-40
CAUSES OF STIGMA IN CANCER PATIENTS: A LITERATURE Tomoko Otsuka REVIEW
Japan
P3-41
THE SPIRITUAL JOURNEY OF FEMALE BREAST CANCER PATIENTS UNDER ADJUVANT THERAPY IN TAIWAN
Taiwan
www.isncc.org
Liao Yu Chen
43
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Program Abstract Title ID
44
Presenter(s)
Country
P3-42
THE APPLICATION EFFECT OF PSYCHOLOGICAL NURSING IN THE NURSING OF TUMOR PATIENTS.
Jing Yao
China
P3-43
CLINICAL APPLICATION OF THE DISTRESS THERMOMETER TO PATIENTS WITH LUNG CANCER
Boyong Shen
China
P3-45
SURVIVORSHIP : A COLLABORATIVE APPROACH
Sian Middleton
United Kingdom
P3-48
SUBJECTIVE EVALUATION OF A PEER SUPPORT PROGRAM BY WOMAN WITH BREAST CANCER.
Miho Ono
Japan
P3-49
SURVIVORSHIP EDUCATION FOR LATINA BREAST CANCER SURVIVORS: EMPOWERING SURVIVORS THROUGH EDUCATION
Gloria Juarez
USA
P3-51
THE EXPERIENCE OF AN ELDERLY CANCER SURVIVOR COUPLE UNDERGOING OUTPATIENT CHEMOTHERAPY
Megumi Nagoshi
Japan
P3-52
FACTORS FOR ENHANCING CANCER SURVIVORS’ INFORMATION LITERACY
Satsuki Kubo
Japan
P3-53
THE EFFECTS OF A SKIN CAMOUFLAGE PROGRAM ON FEMALES WITH HEAD AND NECK CANCER
Shu-Ching Chen
Taiwan
P3-54
SUPPORT, BARRIER, PLANNING ON HEALTHY HABIT AND QUALITY OF LIFE IN COLORECTAL CANCER PATIENTS
Myung Lee
South Korea
P3-55
PROCESS OF BREAST CANCER RECEIVING CHEMOTHERAPY ACCEPT THE CHANGE OF OWN APPEARANCE
Miho Naito
Japan
P3-56
EXPERIENCE OF DEATHBED CANCER PATIENT WITH THE CONCEPT CANCER SURVIVOR
Tu Wen Yi
Taiwan
P3-60
THE EFFECTS OF SEMI-RECUMBENT IN THE EARLY PERIOD AFTER PULMONARY LOBECTOMY
Fen Gu
China
P3-62
SELF-REPORTED DEPRESSION AMONG PATIENTS WITH NON-SMALL CELL LUNG CANCER
Yumei Li
China
P3-63
A STUDY OF NUTRITIONAL STATUS DURING RADIOTHERAPY IN DIFFERENT AGE PATIENTS WITH ESOPHAGEAL CANCER
Yingjun Ye
China
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
PROGRAM
ABOUT OUR SUPPORTERS Asian Oncology Nursing Society (AONS)
Founded in 2013, the Asian Oncology Nursing Society (AONS) is a professional organization which supports cancer nurses to be well-prepared in providing high quality and science based care for cancer patients in Asia. AONS is committed to strengthening collaborations among members, promoting the latest evidence-based practice for improving cancer care, and developing nursing leadership in cancer care in Asia. Learn more at http://aons.asia/mastart/mastart.php
BARD
BARD is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the product fields of Vascular, Urology, Oncology, Surgical Specialty. BARD markets its products and services worldwide to hospitals, individual health care professionals and extended care facilities. BARD’s core values of Quality, Integrity, Service, and Innovation represent our reality and our aspirations. These four values prepare us for the challenges ahead and guide our everyday activities and align us to our mission. They are central to how we behave and want to be viewed by our fellow co-workers, customers, shareholders and communities.
Dale Medical Products, Inc.
Dale Medical Products, Inc. develops and manufactures innovative post-surgical care products for the acute, sub-acute and long-term care markets,
www.isncc.org
designed to save nursing time and reduce skin irritation, while leading to comfortable, trouble-free recovery.
End-of-Life Nursing Education Consortium (ELNEC)
The End-of-Life Nursing Education Consortium (ELNEC) project, which started in 2000, is a national education and international initiative to improve palliative care. The project provides undergraduate and graduate nursing faculty, CE providers, staff development educators, specialty nurses in pediatrics, oncology, critical care and geriatrics, advanced practice registered nurses and other nurses with palliative care education, so they can teach this essential information to nursing students and practicing nurses. To date, over 21,000 nurses and other healthcare professionals, representing all 50 US states, plus 88 international countries have received ELNEC training. The ELNEC project is administered by the American Association of Colleges of Nursing (AACN), Washington, DC and the City of Hope, Los Angeles, CA.
European Oncology Nursing Society (EONS)
The European Oncology Nursing Society is a not for profit, voluntary organisation dedicated to the support and development of European cancer nurses. EONS’s vision is to ensure that people affected by cancer across Europe will benefit from the care of well-educated, informed and competent cancer nurses, who will play a central role in providing support, promoting health and improving clinical outcomes. Website: http://www.cancernurse.eu/
45
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
ICU Medical
ICU Medical helps you maximize clinician and patient safety with easy-to-use, needlefree closed system transfer devices (CSTDs) for the safe administration of hazardous drugs. These CSTDs incorporate passive safety design features into every component, including bonded and locking mechanisms that help minimize hazardous drug exposure and ensure compliance with recommended safe handling guidelines.
International Psycho-Oncology Society (IPOS)
The International Psycho-Oncology Society (IPOS) fosters the science and practice of psychosocial oncology to improve the care people affected by cancer worldwide. The Society seeks to provide leadership and development of standards for education and research on the psychological, social and spiritual factors that affect the quality of life of cancer patients and their loved ones, and that influence tumor progression and survival. The aims of IPOS have been to foster training, encourage psychosocial principles and a humanistic approach in cancer care, and to stimulate research and develop training so psychosocial care may be integrated with all clinical oncological specialties for optimal patient care. IPOS is charitable organization with members from more than 60 different countries. www.ipos-society.org
MERCK & Co., Inc.
USA. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.msd.com or www.msd.XX (for country-specific website).
NCI Center for Global Health The U.S. National Cancer Institute (NCI) Center for Global Health (CGH) is the principal team responsible for coordinating and prioritizing NCI’s global activities to advance global cancer research, build expertise, and leverage resources across nations to address the challenges of cancer and reduce cancer deaths worldwide. CGH’s specific objectives are to: •
Create sustainable international partnerships
•
Support programs that address global gaps in research and scientific training
•
Disseminate information and best practices that drive improvements in cancer research and cancer control
Oncology Nursing Society (ONS)
ONS is a professional association of more than 39,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve quality of life and outcomes for patients with cancer and their families. Learn more at www.ons.org
For 125 years, MSD has been a global health care leader working to help the world be well. MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J.,
46
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
Pfizer Oncology
Pfizer Oncology is committed to the research and discovery of breakthrough treatment options, including small molecules, biologics and immunotherapies, to improve the outlook for cancer patients worldwide. For more information please visit www. pfizer.com.
Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-eight medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines.
PROGRAM
Teva Pharmaceuticals LTD.
Tevadaptor® medical device by Teva Pharmaceuticals LTD. www.tevadaptor.com Tevadaptor® is a closed system for safe compounding and administration of hazardous drugs. Tevadaptor® minimizes the risk of exposure to hazardous drug substances and the risk of needle-stick injuries, protecting the safety of pharmacists, nurses and patients alike. Its patented TOXI-GUARD® system, located in the vial adaptor, allows pressure equalization during use, prevents the escape of hazardous drug vapors into the environment during drug reconstitution and administration and prevents airborne contaminants and particles from entering the drug vial. Tevadaptor® is a brand of Teva Pharmaceuticals LTD. a leading global pharmaceutical company, committed to providing patients with access to high-quality healthcare. Established in 1901, Teva Pharmaceutical Industries Ltd. is ranked among the 10 top pharmaceutical companies in the world. Headquartered in Israel, Teva is active in 60 countries, with 43,000 dedicated employees worldwide. Tevadaptor® keeps you safe in click.
Royal Marsden Hospital
The Royal Marsden Hospital was the first hospital in the world dedicated to cancer treatment and research into the causes of cancer. Today the hospital with its academic partner, The Institute of Cancer Research, forms the largest comprehensive cancer centre in Europe with over 40,000 patients from the UK and abroad seen each year.
www.isncc.org
47
ICCN 2016
48
INTERNATIONAL CONFERENCE on CANCER NURSING
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
EMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE
www.isncc.org
PROGRAM
49
ICCN 2016
INTERNATIONAL CONFERENCE on CANCER NURSING
Notes
50
September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers
ISNCC Membership Membership in ISNCC is available to cancer nursing associations, institutions, and individual cancer nursing professionals worldwide. As a member of ISNCC, you are a part of an international network of professionals in the field of cancer nursing. ISNCC members are encouraged to actively participate in the leadership of the Society by joining ISNCC committees that are working to advance oncology education, research, and patient care. Visit www.isncc.org to join ISNCC! ISNCC memberships expire on December 31 of every year.
INDIVIDUAL MEMBERSHIP Individual nurses or other professionals involved or interested in cancer nursing are eligible to become Individual Members.
• Access to an extensive network of institutions, centers and individuals involved in cancer • Opportunity to collaborate with international nurses through the ISNCC Twinning Program.
ASSOCIATION MEMBERSHIP Oncology and related institutions, charities and organizations are eligible to become Association Members. In addition to the benefits for Individual Members, Association Members also receive the following supplementary benefits: • Option to host an ISNCC webinar and present research conducted at the associate institution. • Marketing of program information via ISNCC communication channels.
As an Individual Member of ISNCC, you are entitled to benefits including:
• Recognition of membership on ISNCC website.
• Exclusive access to ISNCC Insight, a unique platform for nurses to access online educational materials relevant to cancer nursing practice.
FULL MEMBERSHIP
• Electronic subscription to Cancer Nursing, a bimonthly publication that address the whole spectrum of problems arising in the care and support of cancer patients. • Access to the International Cancer Nursing News (ICNN), opportunity to submit blog posts or articles relevant to oncology nursing for consideration by the ISNCC Communications Committee, and receipt of notifications when new posts are made. • Access to the ISNCC Community on Sosido and receipt of weekly digests summarizing all activity in the ISNCC community. • Opportunity to join ISNCC Committees. • Access to ISNCC discussion forum for online dialogue on pertinent international nursing issues. • Discounted subscription rates for inPractice Oncology Nursing, a digital point-of-care reference and educational resource designed specifically for nurses who care for patients with cancer. • Reduced rates on the International Conference on Cancer Nursing (ICCN) registration fees. • Participation in the business meeting of the Society, held during ICCN. • Networking opportunities via participating in society activities. • Access to career postings in the cancer nursing field.
National oncology nursing societies are eligible to become Full Members. In addition to the benefits for Individual Members, Full Members also receive the following supplementary benefits: • Participate in the ISNCC Member Council Meetings, held at the International Conference on Cancer Nursing (ICCN). • Nominate individuals to receive awards or honors conferred by the Society. • Nominate and vote for eligible individuals for the Board of Directors. • Recognition of membership on ISNCC website.
CORPORATE MEMBERSHIP ISNCC invites corporations to help stimulate and support an active and cohesive worldwide oncology nursing community by joining as a Corporate Member. ISNCC has a consistent and successful record of international activities that impact communities by advancing the knowledge and skills of cancer nurses, achieved through partnerships with corporations and cancer organizations. Please contact ISNCC Head Office at
[email protected] if you are interested.
ICCN 2017
INTERNATIONAL CONFERENCE on CANCER NURSING The premier international educational opportunity for nurses The ICCN 2017 will offer the unique opportunity to meet with international cancer nursing leaders from all over the world, in one place at one time.
Submit an Oral or Poster Abstract Register to Attend Participate in a Committee Recommend a Plenary Speaker
Nominate for Awards Reserve your Exhibit Space Book your Educational Symposium or Tutorial
July 9-12, 2017 • Anaheim, California, USA• Sheraton Park Hotel at the Anaheim Resort
visit www.isncc.org for more details
